1. Cell Biology
Download icon

Stress-induced Cdk5 activity enhances cytoprotective basal autophagy in Drosophila melanogaster by phosphorylating acinus at serine437

  1. Nilay Nandi
  2. Lauren K Tyra
  3. Drew Stenesen
  4. Helmut Krämer  Is a corresponding author
  1. UT Southwestern Medical Center, United States
Research Article
  • Cited 3
  • Views 756
  • Annotations
Cite as: eLife 2017;6:e30760 doi: 10.7554/eLife.30760

Abstract

Cdk5 is a post-mitotic kinase with complex roles in maintaining neuronal health. The various mechanisms by which Cdk5 inhibits and promotes neurodegeneration are still poorly understood. Here, we show that in Drosophila melanogaster Cdk5 regulates basal autophagy, a key mechanism suppressing neurodegeneration. In a targeted screen, Cdk5 genetically interacted with Acinus (Acn), a primarily nuclear protein, which promotes starvation-independent, basal autophagy. Loss of Cdk5, or its required cofactor p35, reduces S437-Acn phosphorylation, whereas Cdk5 gain-of-function increases pS437-Acn levels. The phospho-mimetic S437D mutation stabilizes Acn and promotes basal autophagy. In p35 mutants, basal autophagy and lifespan are reduced, but restored to near wild-type levels in the presence of stabilized AcnS437D. Expression of aggregation-prone polyQ-containing proteins or the Amyloid-β42 peptide, but not alpha-Synuclein, enhances Cdk5-dependent phosphorylation of S437-Acn. Our data indicate that Cdk5 is required to maintain the protective role of basal autophagy in the initial responses to a subset of neurodegenerative challenges.

https://doi.org/10.7554/eLife.30760.001

eLife digest

Cells have a problem that we recognize from our own homes: if nobody cleans up, garbage accumulates. Unwanted material in cells can include proteins that clump together and can no longer carry out their normal tasks. If left to build up, these protein aggregates can damage the cell and even kill it. Many neurodegenerative disorders, including Huntington’s disease and Alzheimer's disease, arise when such faulty proteins accumulate inside brain cells.

Autophagy is a process that can destroy protein aggregates and other defective material to keep cells healthy. Understanding how cells regulate autophagy is thus of great interest to scientists. A protein called Acinus promotes autophagy and is found in many organisms including fruit flies and humans. All Acinus proteins share a common feature; they contain a site called Serine437 that can be modified by the attachment of a phosphate group, in a process known as phosphorylation. However, the significance of this modification was not clear.

Nandi et al. have now asked if this phosphorylation event is important for the role of Acinus in autophagy. The experiments were carried out in the fruit fly, Drosophila melanogaster. Flies were engineered such that the normal Acinus protein was replaced with a mutant version that mimics the phosphorylation at Serine437. These mutant flies had higher levels of Acinus, showed more autophagy, and lived longer when compared to normal flies.

Further work identified a protein called Cdk5 as being responsible for attaching phosphate to Acinus at Serine437. Making Cdk5 inactive using experimental tools led to lower levels of autophagy in brain cells and shortened the flies’ life span. Moreover, some aggregation-prone proteins linked to neurodegenerative diseases can enhance the activity of Cdk5 towards Acinus, thereby reducing their own accumulation through elevated autophagy.

Together these findings show that phosphorylation of Acinus by Cdk5 maintains healthy brain cells and improves life span by enhancing autophagy. The next step is to understand how phosphorylation at Serine437 stabilizes Acinus to boost autophagy. This may lead to new ways to adjust the levels of autophagy to benefit different organisms.

https://doi.org/10.7554/eLife.30760.002

Introduction

Cdk5 shares strong homology with other members of the family of cyclin-dependent kinases (Cdks), but it is distinct in its modes of regulation and function (Dhavan and Tsai, 2001; Pozo and Bibb, 2016). Unlike other Cdks, Cdk5 is best known for its function in post-mitotic cells rather than cell cycle regulation (Dhariwala and Rajadhyaksha, 2008). In post-mitotic cells, Cdk5 is regulated by binding to its obligatory membrane-associated p35 or p39 co-activators (Tsai et al., 1994; Tang et al., 1995). These co-activators are highly expressed in the brain and loss of Cdk5 activity in mice or flies has been associated with defects in neurite outgrowth (Su and Tsai, 2011; Trunova et al., 2011), neuronal migration (Nishimura et al., 2014), pre- and post-synaptic functions (Bibb et al., 1999; Li et al., 2001), the maintenance of synaptic plasticity (Hawasli et al., 2007), retinal degeneration (Kang et al., 2012), and neurodegeneration in aging brains (Trunova and Giniger, 2012; Shah and Lahiri, 2017). Accordingly, dysregulation of Cdk5 has been observed in numerous brain diseases, including schizophrenia and epilepsy (Patel et al., 2004; Engmann et al., 2011) and neurodegenerative disorders, including Huntington’s disease, Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS) (Cheung and Ip, 2012). Cdk5 substrates regulating microtubule-based transport (Klinman and Holzbaur, 2015) and synaptic function (Tan et al., 2003; Lai and Ip, 2015), have been identified, but the long-term neuroprotective function of Cdk5 activity remains poorly understood (McLinden et al., 2012; Meyer et al., 2014).

Autophagy, here short for macroautophagy, is a key cellular process for maintaining the health of neurons (Menzies et al., 2015). Cytoprotective functions of autophagosomes in neurons include the engulfment and lysosomal delivery of aggregates of misfolded proteins and the disposal of dysfunctional mitochondria (Green and Levine, 2014). This protective role of basal autophagy was demonstrated by neuron-specific mutations in autophagy core components: neuronal loss of Atg5 or Atg7 yields rapid neurodegeneration (Hara et al., 2006; Komatsu et al., 2006; Juhász et al., 2007). These findings are consistent with results in mouse and Drosophila models of Huntington’s disease or spinocerebellar ataxia type 3 (SCA3) in which elevated autophagy corresponded to reduced loads of aggregated Huntingtin (Htt) protein and ameliorated neuronal phenotypes (Ravikumar et al., 2004; Bilen and Bonini, 2007; Sarkar et al., 2007; Zheng et al., 2010; Jaiswal et al., 2012; Menzies et al., 2015). Although the rapid induction of autophagy in response to glucose or amino-acid deprivation is well described (Galluzzi et al., 2014), little is known about the modulation of basal levels of autophagy in response to stress caused by protein aggregates (Ashkenazi et al., 2017).

We have previously identified Acinus (Acn) as a novel regulator of basal autophagy in Drosophila (Haberman et al., 2010; Nandi et al., 2014). Mammalian Acn had originally been identified as a caspase target aiding in chromatin modifications in apoptotic cells (Sahara et al., 1999; Joselin et al., 2006). In mammalian and Drosophila cells, Acn is highly enriched in the nucleus where, together with its binding partners Sap18 and RNPS1, it forms the ASAP complex (Schwerk et al., 2003; Murachelli et al., 2012). ASAP interacts with the exon junction complex (Tange et al., 2005) and participates in the regulation of alternative splicing (Schwerk et al., 2003; Jang et al., 2008; Hayashi et al., 2014; Malone et al., 2014). Antagonistic activities of Akt1 kinase and caspase-3 homologs regulate Acn levels (Hu et al., 2005) and genetic manipulations that prevent the caspase-mediated cleavage of endogenous Acn in Drosophila can elevate its levels in a cell type-specific manner (Nandi et al., 2014).

An unexpected consequence of such elevated Acn was an increase in basal, starvation-independent autophagy. High-level Acn overexpression by the Gal4/UAS system triggers autophagy-dependent death in Drosophila (Haberman et al., 2010). By contrast, Acn levels were modestly increased by the AcnD527A mutation that interferes with its Caspase-mediated cleavage or by phospho-mimetic mutations in two AKT1 target sites that reduce this cleavage (Nandi et al., 2014). Such mildly elevated Acn levels yielded elevated basal autophagy with beneficial outcomes including enhanced starvation resistance, prolonged life span and reduced loads of polyQ aggregates in a Drosophila model of Huntington’s disease (Nandi et al., 2014).

Here, we show that similar benefits are gained by phosphorylation of Acn at serine 437. We identify Cdk5 as the kinase which mediates this phosphorylation and show that Cdk5 activity is enhanced in the presence of multiple aggregation-prone proteins, including Huntingtin-Q93 (Htt.Q93), SCA3.Q78, and Amyloid-beta peptide 42 (Aβ42). These findings offer new insights into the complex mechanisms balancing the effects of loss and gain-of-function of Cdk5 on neurodegenerative diseases.

Results

Phosphorylation of conserved serine 437 stabilizes Acn

Phosphorylation of conserved C-terminal Akt1-target sites (Figure 1A) regulates Acn levels in flies and mammalian cells (Hu et al., 2005; Nandi et al., 2014). This motivated us to investigate the functional consequences of phosphorylation of another highly conserved residue of Acn, namely serine 437 (Figure 1B). Phosphorylated S437 has been detected by phosphoproteomics approaches in mammalian cancer cells (Patwa et al., 2008; Francavilla et al., 2017) and Drosophila (Bodenmiller et al., 2007).

Figure 1 with 1 supplement see all
Acn protein is stabilized by phosphorylation at Serine 437.

(A) Cartoon shows regulatory elements of Acn. Genomic Acn transgenes are Myc-tagged and expressed from the endogenous acnP promoter in the background of acn1 and acn27 null alleles. Green boxes indicate the RRM domain and regions that bind to AAC11 (Rigou et al., 2009) or SAP18/RNPS1 (Murachelli et al., 2012). Phosphorylation at the AKT1 target sites S641 and S731 reduces Dcp-1-mediated cleavage at D527 (Nandi et al., 2014). (B) Serine S437 is conserved from humans to insects. Sequences shown: Homo sapiens NP_055792.1; Mus musculus AAF89661.1; Danio rerio AAI16537.1; Culex quinquefasciatus XP_001846490.1; Aedes aegypti XP_001664312.1; Apis mellifera XP_006570961.1; Drosophila virilis XP_015028002.1; Drosophila persimilis XP_002014510.1; Drosophila melanogaster NP_609935.1. (C–E) Projections of confocal micrographs of eye discs from AcnWT (C,E) or AcnS437A (D) larvae stained for pS437-Acn and Myc. Strong staining for pS437-Acn is dominated by cone cells (CC) in posterior regions of eye discs, and by photoreceptors cells (PR) closer to the furrow (arrowhead). Staining for pS437-Acn, but not Myc, is reduced to background level in AcnS437A eye discs (D) or after calf intestinal phosphatase (CIP) treatment of AcnWT (E). (F–H) Micrographs focusing on early photoreceptor clusters in eye disc stained for Acn and DNA. Compared to AcnWT (F), Acn levels are reduced for AcnS437A and increased for the phosphomimetic AcnS437D. (I,J) Western blots of larval lysates show elevated levels of AcnS437D compared to AcnWT or AcnS437A. An Acn cleavage product (arrow) removing the N-terminal Myc tag is stable in AcnS437D, but not AcnWT or AcnS437A. (J) Acn levels relative to the Actin loading control are quantified from three blots from biological repeats. (K) RT-qPCR reveals equal expression for Acn transgenes controlled by the endogenous acnP promoter relative to ribosomal protein RP49. Bar graphs show mean ±SD. ns, not significant; ****p<0.0001; each compared to wild-type Acn control. Scale bar in E is 50 µm in C-E, scale bar in F is 10 µm in F-H. Detailed genotypes are listed in Supplementary file 3.

https://doi.org/10.7554/eLife.30760.003

To explore phosphorylation of this residue in vivo, we raised an antibody that specifically recognizes Acn phosphorylated at serine 437. To assess its specificity for S437-phosphorylated Acn (pS437-Acn), we generated flies in which endogenous Acn was replaced by N-terminally Myc-tagged AcnWT or AcnS437A (Figure 1A). Expression of these transgenes was under control of the endogenous acn promoter and enhancers within a 4 kb acn genomic region (Nandi et al., 2014). All genomic acn transgenes were inserted at 96F3 to avoid insertion site-specific differences in expression levels (Figure 1K). The previously observed lethality, developmental defects and endocytic trafficking defects of acn-null alleles were rescued by both transgenes and also a corresponding phospho-mimetic AcnS437D (Figure 1—figure supplement 1). From here on, we will refer to these rescued flies that, in an acn-null background exclusively express transgenic forms of Acn as AcnWT, AcnS437D or AcnS437A flies. Full genotypes for each experiment are listed in Supplementary file 3.

Staining of AcnWT larval eye discs with the phospho-specific pS437-Acn antibody revealed a dynamic expression pattern consistent with staining for the Myc epitope tag (Figure 1C) and the previously described distribution of Acn in retinal cells (Haberman et al., 2010; Nandi et al., 2014). Two approaches were used to assess specificity for pS437-Acn. First, staining with pS437-Acn antibody of AcnS437A eye discs was reduced to background level (Figure 1D). Second, treatment of AcnWT eye discs with Calf Intestinal Phosphatase (CIP) reduced staining for pS437-Acn but not the Myc epitope (Figure 1E), demonstrating the specificity of the pS437-Acn antibody and the high level of Acn phosphorylation at S437 in developing eye discs.

To test the effect of S437 phosphorylation on Acn levels, we stained the larval eye disc with Acn antibody. Acn levels were slightly reduced in AcnS437A eye discs compared to AcnWT (Figure 1F,G). The small difference between AcnWT and AcnS437A levels in western blots of larval lysates (Figure 1I) may reflect the contribution of other tissues with low levels of S437 phosphorylation of AcnWT or with AcnS437A stabilized by alternative mechanisms. By contrast, Acn levels were further enhanced in flies expressing only the phospho-mimetic AcnS437D (Figure 1H). This was consistent with changes in Acn levels when compared by western blot analysis of larval lysates: AcnS437D levels were elevated compared to AcnWT or phospho-inert AcnS437A (Figure 1I,J). Moreover, we detected a smaller form of Acn that lost the N-terminal Myc-epitope (arrow in Figure 1I). This likely represents a cleaved form of Acn that was stabilized for phospho-mimetic AcnS437D but degraded for AcnWT or AcnS437A (Figure 1I). Proteolytic cleavage of Acn close to the S437 residue has previously been observed for Drosophila and mammalian Acn proteins (Sahara et al., 1999; Hu et al., 2005; Nandi et al., 2014). Together, these data indicate that Acn S437 is phosphorylated in developing tissues and plays a critical role in regulating Acn levels.

Stabilized Acn elevates basal autophagy

As altering Acn levels can modulate the level of basal autophagy (Nandi et al., 2014), we tested whether the stabilized AcnS437D mutant exhibited elevated levels of autophagy. First, we analyzed endogenous Atg8a in eye discs of fed wandering third instar larvae. Atg8a punctae mark autophagosomes and early autolysosomal structures (Klionsky et al., 2016). The number of Atg8a-positive punctae was higher for phosho-mimetic AcnS437D eye discs compared to AcnWT or phospho-inert AcnS437A, indicating elevated levels of autophagy (Figure 2A–D). Another tissue with highly regulated autophagy are larval fat bodies (Rusten et al., 2004; Scott et al., 2004). When we examined fat bodies of fed 96 hr larvae, Atg8a punctae were rare in AcnWT or AcnS437A larvae, but numerous and brightly stained in fed AcnS437D larval fat bodies (Figure 2E–H, Figure 2—figure supplement 1A). Importantly, a 4-hr amino acid starvation further increased the accumulation of Atg8a punctae in all three genotypes (Figure 2I–L, Figure 2—figure supplement 1).

Figure 2 with 1 supplement see all
Stabilized AcnS437D enhances basal autophagy.

(A–C) Micrographs of fed AcnWT, AcnS437A or AcnS437D larval eye discs stained for Atg8a. Scale bar: 40 µm in A-O. (D) Quantification of Atg8a punctae in eye discs from five larvae. (E–G, I–K, M–O) Micrographs of AcnWT, AcnS437A or AcnS437D larval fat bodies encompassing 6 to 8 cells from 96 hr fed or starved size-matched larvae (as indicated) stained for ATG8a (E–G, I–K) or with Lysotracker (M–O). For panels E’-G’ and I’-K’ lysosomal degradation was inhibited with chloroquine to visualize autophagic flux. (H,L,P) Quantification of Atg8a intensity (H,L) or Lysotracker punctae (P) in fat bodies averaged from six to eight cells from four to five larvae from one representative experiment out of three repeats. (Q,R) TEMs of fed AcnWT or AcnS437D fat bodies. Smaller panels show higher magnification examples of dense lysosomes (arrowheads), membrane-enriched autolysosomes (arrows) and mitochondria (m). Scale bars are 2 µm. (S) Quantification of diameters of at least 100 lysosomes and autolysosomes per genotype. (T) Quantification of percentage of autolysosomal area averaged from 25 images per genotype. Bar graphs show mean ± SD. **p<0.01; ****p<0.0001; ns, not significant; each compared to corresponding fed or starved wild-type Acn control. For each genotype, starved and fed were significantly different (p<0.01). Significant differences between untreated and chloroquine-treated larvae are indicated (##p<0.01; ###p<0.001, ####p<0.0001). Detailed genotypes are listed in Supplementary file 3.

https://doi.org/10.7554/eLife.30760.006

We used three approaches to distinguish whether the elevated levels of Atg8a punctae in fed AcnS437D larvae represent an accumulation of stalled autophagosomes, or elevated flux through the pathway.

First, we inhibited lysosomal acidification and degradation with chloroquine to reveal Atg8a that has been delivered to autophagosomes and otherwise would be degraded (Lőw et al., 2013; Mauvezin et al., 2014). For AcnWT, AcnS437A and AcnS437D fat bodies, chloroquine treatment resulted in further elevation of ATG8a staining after starvation, consistent with elevated flux in these starved tissues (Figure 2I’–L, Figure 2—figure supplement 1). Chloroquine treatment also significantly enhanced ATG8a staining in fed AcnS437D fat bodies consistent with elevated autophagic flux (Figure 2G’, H, Figure 2—figure supplement 1).

Second, we used LysoTracker to evaluate acidification of autolysosomes and lysosomes (DeVorkin and Gorski, 2014a). Under fed conditions, few LysoTracker-positive punctae were detected in AcnWT or AcnS437A fat bodies, and their number increased upon amino acid starvation (Figure 2M–P), consistent with previous reports of starvation-induced autophagic flux in larval fat bodies (Rusten et al., 2004; Scott et al., 2004). AcnS437D larval fat bodies, however, displayed numerous LysoTracker-positive structures even in fed 96 hr larvae (Figure 2O,P) and their number further significantly increased after a 4 hr amino acid starvation (Figure 2O’,P).

Third, we analyzed these changes on the ultrastructural level using transmission electron microscopy (TEM). Previous work has shown that fat bodies from fed wild-type larvae contain predominately lysosomes smaller than 400 µm, while starved fat bodies contain lysosomes and autolysosomes larger than 1 µm (e.g. Scott et al., 2004; Takáts et al., 2013; Takáts et al., 2014). When we analyzed fat bodies of fed 96 hr AcnS437D larvae, we observed significantly larger and more abundant lysosomes and autolysosomes compared to AcnWT (Figure 2Q,R). The mean diameter of lysosomal/autolysosomal structures is increased more than eight-fold from 250 ± 20 nm in AcnWT to 2044 +/−135 nm in AcnS437D larvae (Figure 2—figure supplement 2S) and the mean area they occupied was increased almost 65-fold (Figure 2T).

We previously observed that increased levels of Acn exert a concentration-dependent physiological response. Mild elevation, for example by preventing caspases-mediated cleavage of Acn, enhanced starvation resistance and extended life span of well-fed flies (Nandi et al., 2014). By contrast, da-Gal4-driven expression at higher levels caused autophagy-mediated lethality (Haberman et al., 2010). Therefore, we explored the physiological consequences of elevated autophagy in AcnS437D flies. When challenged with starvation stress, AcnS437D flies survived significantly longer than AcnWT or AcnS437A flies (Figure 3A). Furthermore, AcnS437D life span under well-fed conditions was significantly extended, whereas the phospho-inert AcnS437A mutants died somewhat faster compared to AcnWT (Figure 3B). The median life expectancy for the stabilized AcnS437D mutant was extended by about 50% to 57 days compared to 38 days for AcnWT. Together, our data indicate that stabilized phospho-mimetic AcnS437D elevates basal autophagy leading to beneficial outcomes under standard growth conditions.

Stabilized AcnS437D enhances life span.

(A) Starvation-induced mortality of flies expressing the indicated Acn proteins. In parenthesis shown are numbers of initial flies in a single representative experiment out of three. (B) Survival curves of flies expressing the indicated Acn proteins. In parenthesis shown are numbers of initial flies in a single representative experiment out of three. Log-rank comparisons revealed significant differences between survival curves: *p<0.05; ****p<0.0001.

https://doi.org/10.7554/eLife.30760.012

Cdk5 phosphorylates Acn at serine 437

To identify the kinase responsible for phosphorylating Acn at serine 437, we performed a targeted RNAi screen. We screened a pre-selected subset of kinases based on hits in software packages [GPS3.0; http://gps.biocuckoo.org (Xue et al., 2008) and NetPhosK http://www.cbs.dtu.dk/services/NetPhosK/ (Miller and Blom, 2009). To test the ability of these kinases to modify Acn function, we used a sensitized genetic system. Eye-specific GMR-Gal4-driven expression of UAS-AcnWT at 28°C yields a rough-eye phenotype that is susceptible to enhancement or suppression by modifiers of Acn levels (Nandi et al., 2014). We reasoned that reduced activity of any kinase responsible for phosphorylating and stabilizing Acn should at least partially suppress the roughness induced by UAS-AcnWT. Among the kinases tested, RNAi lines targeting Cdk5 and the MAP kinase p38b exhibited more than 50% suppression of Acn-induced eye roughness (Figure 4, Figure 4—figure supplement 1, Supplementary file 1). Moreover, expression of UAS-Cdk5-RNAi and UAS-p38b RNAi transgenes by themselves did not result in visible phenotypes in the eye (Figure 4F,M and Supplementary file 1).

Figure 4 with 2 supplements see all
Acn genetically interacts with p38b MAP kinase and Cdk5/p35.

SEM images of eye expressing the indicated transgenes under GMR-Gal4 control at 28°C. (A) Expression of UAS-AcnWT causes a rough eye. This eye-roughness is suppressed by knockdown of p38b MAPK (B) or co-expression of dominant-negative p38b MAPKK53R (C). By contrast, co-expression of wild-type p38b MAPK enhances the roughness (D). Expression of Gal4 (E) or the indicated p38b MAPK transgenes in the absence of UAS-AcnWT (F–H) causes little or no changes in eye morphology. Eye-roughness induced by UAS-AcnWT is suppressed by knockdown of Cdk5 (I) or co-expression of dominant-negative Cdk5K33A (J). By contrast, co-expression of wild-type Cdk5 (K) or the required cofactor p35 (L) enhance AcnWT-induced roughness. Expression of the indicated Cdk5 and p35 transgene in the absence of UAS-AcnWT (M–P) causes little or no changes in eye morphology. Scale bar in A-P: 50 µm. Quantification of genetic interactions is shown in Supplementary files 1 and 2. Detailed genotypes are listed in Supplementary file 3.

https://doi.org/10.7554/eLife.30760.013

We further investigated these two hits from the RNAi screen by examining interactions of gain-of-function and loss-of-function mutants with Acn. GMR-Gal4-driven co-expression of AcnWT with the dominant-negative kinases p38b MAPKK53R or Cdk5K33A effectively suppressed the rough-eye phenotype (Figure 4C,J, Figure 4—figure supplement 2 and Supplementary file 2). Furthermore, co-expression of AcnWT with p38b MAPK, Cdk5 or its coactivator p35 (Tsai et al., 1994; Connell-Crowley et al., 2000) further enhanced eye roughness (Figure 4D,K,L and Supplementary file 2). By contrast, expression of these indicated Cdk5/p35 and p38b MAPK transgenes by themselves yielded little to no visible eye phenotypes (Figure 4G,H,N–P and Supplementary file 2). These strong genetic interactions with Acn point to Cdk5 and p38b MAPK as two candidate kinases that may phosphorylate Acn and thereby enhance its activity.

To test whether genetic interactions reflect modification of Serine 437, we used the phospho-specific pS437-Acn antibody to stain eye tissue from wandering third instar larvae. Larvae with Cdk5 or p35 knocked down, as well as Cdk5 or p35 mutant larvae exhibited a dramatic reduction of Acn phosphorylation at serine 437 compared to wild-type controls (Figure 5A–I). Some brightly pS437-Acn-positive cells remained, however, close to the morphogenetic furrow of Cdk5 or p35 loss-of-function eye discs. In wild-type (Figure 5B,C) and Cdk5 loss-of-function eye discs (Figure 5E,F), the apical position of these pS437-Acn-positive cells and their shape and DNA distribution identified them as mitotic cells (Figure 5C,F). In dividing cells, Acn may be phosphorylated, possibly by mitotically active kinases of the Cdk family with target recognition sequences similar to Cdk5 (Malumbres and Barbacid, 2009). Interestingly, Cdk1 knockdown enhanced the Acn overexpression phenotype in eyes (Supplementary file 1). As AcnS437A or AcnS437D flies are viable and without obvious mitotic defects, we did not further analyze the significance of elevated pS437-Acn levels in mitotic cells.

Cdk5/p35-mediates phosphorylation of Acinus.

Projections (A, D, G–L) or individual optical sections (B,C,D,E) of confocal micrographs of eye discs stained for pS437-Acn or DNA from wild-type controls (A–C), or from larvae with knockdown for Cdk5 (D–F), mutant for Cdk5 (G) or p35 (H), or with p35 knockdown (I), or Cdk5 mutant larvae rescued with a genomic Cdk5 transgene (J), from larvae overexpressing p35 (K) or mutant for p38b MAP kinase (L). Arrows indicate examples of mitotic cells with high pS437-Acn levels. These are best seen in individual optical sections of wild-type (B,C) or Cdk5-RNAi eye discs (E,F). Scale bar is 50 µm in A, D,E, G-L; 32 µm in B; 10 µm in C; and 15 µm in F.

https://doi.org/10.7554/eLife.30760.017

Importantly, in Cdk5 mutant larvae, Acn phosphorylation at serine 437 was restored to wild-type levels with a genomic Cdk5 transgene (Figure 5J). Furthermore, overexpression of p35 drastically enhanced Acn-S437 phosphorylation (Figure 5K). By contrast, in p38b mutant larvae pS437-Acn levels were not altered compared to wild type (Figure 5A,L). These data suggest that although both Cdk5 and p38b MAPK genetically interact with Acn, only Cdk5/p35 mediates phosphorylation of Acn-S437.

To further test the in vivo importance of S437 phosphorylation by Cdk5, we compared GMR-Gal4-driven co-expression of UAS-p35 or UAS-p38b MAPK with UAS-AcnWT or UAS-AcnS437A, respectively. At 25°C, UAS-AcnWT or UAS-AcnS437A expression yielded mildly rough eyes (Figure 6A,B), and expression of only p35 or p38b MAPK did not alter eye morphology (Figure 6C,D). Notably, co-expression of p35 enhanced UAS-AcnWT-induced roughness significantly more than that of AcnS437A (Figure 6E,F,I; p<0.0001; Chi-square test). By contrast, both UAS-AcnWT and UAS-AcnS437A rough-eye phenotypes were enhanced by p38b MAPK co-expression (Figure 6G,H,I). Furthermore, Acinus S437 phosphorylation by Cdk5 was also observed in vitro, when purified Acinus proteins, either bacterially-expressed GST-Acn402-527 fusion proteins (Figure 6J) or S2 cell-expressed full-length Acinus proteins (Figure 6K) were exposed to purified Cdk5/p35 kinase complex. Together these findings indicate that, unlike for p38b MAPK, Acn S437 is the physiologically relevant residue targeted by the Cdk5/p35 complex.

Acn-S437 is the critical target site for Cdk5/p35-mediated phosphorylation.

(A–H) SEM images of eyes expressing the indicated transgenes under UAS/GMR-Gal4 control at 25°. Under these conditions, expression of AcnWT (A) or AcnS437A (B) causes a mildly rough eye, but not expression of p35 (C) or p38b MAP kinase (D). Coexpression of p35 with AcnWT (E) causes a severely rough eye, but not p35 coexpression with AcnS437A (F). By contrast, p38b MAP kinase coexpression enhances roughness of both, AcnWT (G) and AcnS437A (H). Quantification of these genetic interactions is shown in panel I. Statistical significance was calculated by Chi square test (****p<0.0001; ns, not significant). (J–K) Western blots of purified wild-type (WT) or S437A mutant (SA) GST-Acn402-527 fusion proteins (J) or full-length Streptag-Myc-Acn proteins (K) that were incubated with the indicated amount of Cdk5/p35 kinase complex. Blots were developed with antibodies against pS437-Acn (1:2000), Myc (1:2000), or total Acn (1:2000) as described (Nandi et al., 2014). Note that the Acn antibody (Haberman et al., 2010) preferentially recognizes a C-terminal Acn epitope that is deleted in some of the partially degraded GST-fusion proteins, which however still contain the Cdk5 target site at S437. Detailed genotypes are listed in Supplementary file 3.

https://doi.org/10.7554/eLife.30760.018

Acn regulates basal autophagy and life span by Cdk5/p35-dependent phosphorylation

Flies mutant for the Cdk5 co-activator p35 display adult onset neurodegeneration and reduced lifespan (Connell-Crowley et al., 2007; Trunova and Giniger, 2012). To test whether altered basal autophagy contributes to these phenotypes, we first examined the distribution of Atg8a in eye discs from fed 96-hr old larvae. Compared to wild type (Figure 7A), p35 mutant eye discs displayed a significantly reduced number of Atg8a-positive punctae (Figure 7B,K). Basal autophagy in p35 eye discs was restored to wild-type level by expression of phospho-mimetic AcnS437D, but not AcnWT or AcnS437A, under control of the endogenous acn promoter (Figure 7C–E,K). Cellular levels of the autophagy receptor p62 depend on autophagic flux and thus are elevated in cells with impaired basal autophagy (Pircs et al., 2012; DeVorkin and Gorski, 2014b). By immunostaining, p62 levels were significantly elevated in p35 eye discs compared to wild type (Figure 7F,G,L), consistent with impaired basal autophagy. Accumulation of p62 in p35 eye discs was not prevented by expression of AcnWT or AcnS437A (Figure 7H,I,L), whereas AcnS437D expression restored wild-type p62 levels (Figure 7J,L).

Cdk5/p35-mediated phosphorylation of Acn regulates basal autophagy and longevity.

Projections of confocal micrographs of eye discs stained for Atg8a (A–E) or p62 (F–J) from wild-type controls (A,F), p35 mutant larvae (B,G) or p35 mutant larvae expressing AcnWT (C,H), AcnS437A (D,I) or the phosphomimetic AcnS437D (E,J) under control of the acnP promoter. Scale bar in A is 40 µm in A-J. (K) Quantification of Atg8a punctae from three eye discs each with genotypes as shown in A-E. (L) Quantification of p62 punctae from three eye discs each with genotypes as shown in F-J. Bar graphs show mean ±SD. ns, not significant; **p<0.01; ***p<0.001; ***p<0.0001; each compared to wild-type Acn control. (M) Survival curves of WT controls or p35 mutants, or p35 mutants expressing the indicated Acn proteins. The initial numbers of flies were 95 (WT), 121 (p35), 116 (p35, AcnWT), 111 (p35, AcnS437A), 90 (p35, AcnS437D). Log rank tests compared to WT control: ns, not significant; ****p<0.0001. Detailed genotypes are listed in Supplementary file 3.

https://doi.org/10.7554/eLife.30760.019

Next, we explored the physiological consequences of manipulating levels of basal autophagy in p35 mutants. Consistent with previous reports (Connell-Crowley et al., 2007), p35 mutants had reduced life expectancy compared to wild type (Figure 7M). Near wild-type life span was restored in p35 mutants that express phospho-mimetic AcnS437D, but not AcnS437A or AcnWT (Figure 7M). Together, these data indicate that Acn-S437 is a physiologically relevant target for Cdk5/p35-mediated phosphorylation.

Protein aggregation triggers phosphorylation of Acn S437

To maintain normal life span, autophagy is required in neurons for the suppression of neurodegeneration. To test a possible role of Cdk5-mediated Acn phosphorylation in this context, we used two different Drosophila Huntington’s disease models expressing huntingtin-polyQ polypeptides in the eye, either through GMR-Gal4-driven expression of UAS-Htt.Q93 (Figure 8B,C) or through a direct fusion of Htt-Q120 with the GMR enhancer/promoter region (GMR-Htt.Q120, Figure 8D,E). Compared to wild-type eye discs (Figure 8A), Acn-S437 phosphorylation was elevated in posterior cells of Htt-polyQ expressing eye discs (Figure 8B,D,F). This activation of Acn was dependent on Cdk5/p35 as it was suppressed in eye discs with p35 knocked down (Figure 8C,F) or mutant for p35 (Figure 8E,F).

Protein-aggregate-induced phosphorylation of Acn S437 depends on Cdk5/p35.

Projections of confocal micrographs of eye discs stained for pS437-Acn (A–E) or polyQ proteins (G–K) and DNA. Compared to a GMR-Gal4 control (A), GMR-Gal4-driven UAS-Htt.Q93 (B) or GMR-Htt.Q120 (D) expression induced elevated S437 phosphorylation, which was suppressed in eye discs with p35 knockdown (C) or mutant for p35 (E). GMR-directed expression initiates at the furrow (arrowhead) and is more developed toward the posterior. (F) Quantification of S437 phosphorylation (F) averaged constant areas containing about 50 ommatidial clusters located at least 6–8 rows posterior to the furrow. Bar graphs show mean ±SD of integrated densities. Values were normalized to GMR-Gal4 controls and were from one representative experiment out of three repeats. ns, not significant; **p<0.01; ***p<0.001; ***p<0.0001; for indicated comparisons. Early polyQ accumulation was compared between GMR-Gal4 eye discs as controls (G), and eye discs expressing GMR-Htt.Q120 and carrying a copy of the indicated genomic Acn transgene (H–J) or the p35 null allele (K). Compared to AcnWT (H) and AcnS437A (I) eye discs, in AcnS437D (J) polyQ accumulation was reduced until some 7 to 8 rows of ommatidia posterior to the furrow (arrowhead) and enhanced in p35 mutants (H). Scale bar in A: 40 µm in A-N. Posterior is to the left. (L) Quantification of PolyQ accumulation averaged constant areas containing about 100 ommatidial clusters located at least 2–3 rows posterior to the furrow. Bar graphs show mean ± SD of integrated densities. Values were normalized to AcnWT/GMR-Htt.Q120 (L) and were from one representative experiment out of three repeats. ns, not significant; **p<0.01; ***p<0.001; ***p<0.0001; compared to AcnWT/GMR-Htt.Q120. (M) Quantification of dot blots measuring aggregated polyQ protein in fly heads expressing GMR-Htt.Q120 and the indicated genomic Acn transgenes or in a p35 mutant background. Control OreR flies (+/+) indicate background level of dot blot measurements (n = 3 biological repeats). The scatter plot shows mean and standard deviation from three separate experiments. Detailed genotypes are listed in Supplementary file 3.

https://doi.org/10.7554/eLife.30760.021

To examine the consequence of Acn activation for polyQ accumulation, we stained eye discs for polyQ proteins. GMR-Htt.Q120 expression resulted in its accumulation a few rows posterior to the furrow in eye discs expressing AcnWT or AcnS437A under control of the acn promoter (Figure 8G–I,L). By contrast, expression of the stabilized phospho-mimetic AcnS437D protein yielded an initial reduction in polyQ accumulation just posterior to the furrow (Figure 8J,L). This is consistent with the data above that show elevated autophagy in AcnS437D eye discs (Figure 2A,C) and with the known role of autophagy in the clearance of protein aggregates (Menzies et al., 2017). In p35 mutant eye discs, polyQ protein levels were further elevated (Figure 8K,L), which resulted in the accumulation polyQ aggregates in adults as detected by a filter retardation assay (Figure 8M).

Acn activation was not specific for Htt-polyQ peptides, as overexpression of other neurodegeneration linked polyQ proteins, specifically SCA3.Q78 (Figure 9B,G) and ATX1.Q82 (Figure 9C,G) yielded similar increases in Acn-S437 phosphorylation. Furthermore, expression of human Aβ42 peptide resulted in elevated levels of S437 phosphorylated Acn (Figure 9D,G). By contrast, overexpression of Parkinson’s disease-linked alpha-Synuclein (Figure 9E,G) or Amyotrophic Lateral Sclerosis (ALS)-linked human SOD1 (Figure 9F,G) in larval eye disc failed to elevate Acn S437 phosphorylation compared to wild type (Figure 9A).

Increased Acn-S437 phosphorylation is specific for a subset of neurodegeneration models.

Projections of confocal micrographs of eye discs stained for pS437-Acn (A–F) or DNA (A’–F’). Compared to GMR-Gal4 controls (A), eye discs with GMR-Gal4-driven UAS-SCA3.Q78 (B) or UAS-ATX1.Q82 (C) or UAS-Aβ42 (D) display elevated levels of pS437-Acn staining in a subset of cells, in contrast to UAS-alpha-Synuclein (E) or UAS-hSOD1 (F) which appear unaltered compared to controls. GMR-directed expression of transgenes initiates at the furrow (arrowhead) and extends toward the posterior (left). Scale bar in A is 40 µm in A-N. Detailed genotypes are listed in Supplementary file 3. (G) Quantifications of S437 phosphorylation averaged constant areas containing about 50 ommatidial clusters located at least 6–8 rows posterior to the furrow. Bar graphs show mean ±SD of integrated densities of pS437 staining normalized to GMR-Gal4 controls. ns, not significant; **p<0.01; ***p<0.001; ***p<0.0001; compared to GMR-Gal4/+.

https://doi.org/10.7554/eLife.30760.023

Discussion

Numerous studies have implicated dysregulation of Cdk5 activity in neurodegenerative diseases due to its role in regulating cytoarchitecture, axonal transport, and synaptic activity (Su and Tsai, 2011; Cheung and Ip, 2012; Shah and Lahiri, 2017). Here, we show that reduced Cdk5 activity can also reduce neuronal fitness by compromising basal autophagy. We find that the effect of the Cdk5/p35 complex on autophagy depends on its role in phosphorylating the conserved S437 in Acn. Interfering with Acn-S437 phosphorylation, either by loss of Cdk5/p35 function, or by mutation of its target site in Acinus, reduces the level of basal, starvation-independent autophagy and shortens life span. Importantly, these phenotypes were reversed by the phospho-mimetic AcnS437D mutation. The beneficial outcomes that result from Acinus stabilization, including the extended lifespan and suppression of polyQ protein accumulation (our data and Nandi et al., 2014), argue that increases in autophagic flux and autolysosome size in stabilized phospho-mimetic AcnS437D mutants are not a response to a proteotoxic stress or reflective of a defect in lysosomal function due to AcnS437D expression, but reflect a beneficial activation of autophagy as previously observed in multiple systems (e.g. Sarkar et al., 2007; Simonsen et al., 2008; Menzies et al., 2015; Gelino et al., 2016). Therefore, these findings indicate the importance of Cdk5-mediated Acn-S437 phosphorylation for maintaining neuronal health.

How does phosphorylation of S437 stabilize Acinus and boost its function? One possibility is a reduction in caspase-mediated cleavage of Acinus (Sahara et al., 1999). Inhibition of this cleavage has previously been shown as a consequence of Akt1-mediated Acinus phosphorylation in apoptotic (Hu et al., 2005) and also in non-apoptotic cells (Nandi et al., 2014) and furthermore, upon binding of the anti-apoptotic protein AAC11 (Rigou et al., 2009). Our data, however, argue against this possibility. We have previously shown that preventing its caspase-mediated cleavage in the AcnD527A mutant stabilized Acn only in a subset of photoreceptor cells (predominantly R3 and R4, Nandi et al., 2014). By contrast, S437 phosphorylation elevates Acinus levels in the majority of photoreceptor cells (Figure 1). We thus favor the notion of a different Acn cleavage, closer to the S437 residue. Such a cleavage has been reported for mammalian Acinus (Sahara et al., 1999) at a residue corresponding to A423 in Drosophila Acn. It will be important to identify the protease responsible for this cleavage and test its impact on Acn function.

In the context of neurodegenerative diseases, much interest has been focused on the aberrant activation of Cdk5. Elevated Cdk5 activity can be induced by multiple stressors such as inflammation, ischemia, or mitochondrial dysfunction (Su and Tsai, 2011). These stressors can trigger pathological activation of Cdk5 by calpain-mediated cleavage of its p35 or p39 co-activators (Lee et al., 2000). The cleavage product p25 lacks the myristoylation-tag that anchors activated Cdk5 in complexes with p35 or p39 to membranes and escapes the inhibitory auto-phosphorylation of p35/39 that limits their life time in active complexes (Patrick et al., 1999). The resulting unrestrained phosphorylation of proteins involved in microtubule-based axonal transport and synaptic proteins contributes to the progression of ALS, Alzheimer’s diseases and other neurological diseases (McLinden et al., 2012; Klinman and Holzbaur, 2015).

In Drosophila, we observe Cdk5-depedent elevated Acn-S437 phosphorylation in response to the expression of polyQ proteins, but we do not know yet whether this increase reflects elevated Cdk5/p35 activity or pathological Cdk5/p25 activity following calpain-mediated cleavage of p35. Alternatively, the phosphatases that remove the phosphate group from pS437- Acn may be inhibited. Acn-S437 phosphorylation is highly dynamic in developing eyes (Figure 1), but phosphatases acting on pS437-Acn have not yet been identified. Interestingly, in addition to multiple polyQ proteins, Aβ42 expression is another Drosophila neurodegenerative disease model that triggered elevated phosphorylation of Acn-S437. This is consistent with increased Cdk5 activity reported for multiple Alzheimer’s disease models (Otth et al., 2002; Shah and Lahiri, 2017) which in turn may contribute to the Cdk5-dependent phosphorylation of Tau as a possible contribution to the progression of Alzheimer’s disease (Cruz et al., 2003).

Not all neurodegeneration models induced Cdk5 activity as visualized by Acn-S437 phosphorylation. Pathological Cdk5 activation is believed to contribute to Parkinson’s disease (Smith et al., 2006). Nevertheless, overexpression of alpha-Synuclein, which mimics some aspects of Parkinson’s disease in Drosophila (Kontopoulos et al., 2006), is not sufficient to increase pS437-Acn levels. Similarly, Acn phosphorylation was unchanged in response to hSOD1 over-expression in a Drosophila model of ALS (Watson et al., 2008). Both of these models trigger substantial cellular stress and rapid neurodegeneration (Jaiswal et al., 2012), indicating that Acn phosphorylation is not a generic response to cellular stress, but more likely involves specific activation of Cdk5.

An example of such a specific interaction was recently elucidated in the context of polyQ proteins. Ashkenazi et al. (2017) showed that the levels of the autophagy regulator Beclin1 are maintained by its Ataxin3-mediated de-ubiquitination. Their interaction is mediated by the polyQ tract in wild-type Ataxin3 and inhibited by the presence of pathological polyQ tracts known to trigger Huntington’s disease or SCA3 (Ashkenazi et al., 2017). Furthermore, an increasing number of autophagy receptors are being identified that drive selective autophagy of specific cargoes (Rogov et al., 2014; Khaminets et al., 2016). Interestingly, several of these receptors are activated by modifications such as phosphorylation or ubiquitination in response to specific stressors, such as polyQ proteins (Deng et al., 2017). To which extend such modifications of autophagy receptors contribute to the induction of basal autophagy by Acn remains to be tested.

Intriguingly, Cdk5-mediated phosphorylation stabilizes Huntingtin (Luo et al., 2005) and thereby may promote its function as a scaffold for selective autophagy (Ochaba et al., 2014; Rui et al., 2015). Cdk5 may thus act through different effectors in different diseases. Endophilin B1 was identified as a Cdk5 substrate, the phosphorylation of which is required for starvation-induced autophagy (Wong et al., 2011). Importantly, Cdk5-mediated phosphorylation of Endophilin B1 appeared necessary for the elimination of dopaminergic neurons in an MPTP mouse model of Parkinson's disease (Wong et al., 2011). Furthermore, MEKK1 is a key target for Cdk5 in a Drosophila model of retinitis pigmentosa (Kang et al., 2012). Such diversity of targets may not only apply to different diseases, but also to different stages of a given disease.

Although the pathological activation of Cdk5 activity appears to be a contributing factor to the progression of some neurodegenerative diseases, we show that wild-type levels of Cdk5/p35 activity are necessary to support basal autophagy in the clearance of protein aggregates. We show that this effect, at least in part, is due to Cdk5-mediated phosphorylation of Acn as phospho-mimetic AcnS437D reverses the reduced basal autophagy and the shortened life span observed in p35 mutants due their adult-onset, progressive neurodegeneration (Connell-Crowley et al., 2007; Trunova and Giniger, 2012).

How does the Cdk5-mediated phosphorylation of Acn-S437 elevate the level of basal autophagy? We previously have shown that levels of Acn are critical for regulating basal autophagy in an Atg1-dependent manner (Nandi et al., 2014). High Acn levels can drive excessive autophagy, even in the presence of activated mTor, and cause autophagy-dependent lethality (Haberman et al., 2010). More subtle effects resulted when inhibiting caspase-mediated cleavage or phospho-mimetic mutations elevated levels of Acinus expressed from its own promoter (Nandi et al., 2014, Figure 1). For example, the phosphorylation of two conserved Akt1-target sites has been shown to elevate Acn levels (Hu et al., 2005; Nandi et al., 2014). In Drosophila, this stabilized Acn promotes starvation-independent basal autophagy (Nandi et al., 2014). Similarly, we find that Cdk5-mediated phosphorylation stabilizes Acn protein and promotes autophagy (Figure 7), as does the phospho-mimetic AcnS437D mutation (Figure 2). Nevertheless, stabilized Acinus proteins do not reach the levels necessary to cause the developmental defects that can be triggered by overexpression through the Gal4/UAS system (Haberman et al., 2010; Nandi et al., 2014).

Nuclear localization of Acn as a Cdk5 substrate seems to be in conflict with the localization of the activated Cdk5/p35 complex to the plasma membrane due the myristoylation of p35 (Patrick et al., 1999). However, non-myristoylated p35 and p39 preferentially accumulate in the nucleus and can bind and activate nuclear Cdk5 (Asada et al., 2008). How nuclear or possibly cytoplasmic Acn induces autophagy remains unclear. Phosphorylated and unphosphorylated Acn proteins are primarily nuclear and neither phosphorylation at S437 nor the two Akt1 target sites S641 and S731 are necessary for starvation-induced autophagy, although they enhance basal autophagy (Figure 2 and Nandi et al., 2014). Acn is a required component of the nuclear ASAP complex (Schwerk et al., 2003; Murachelli et al., 2012) which participates in the regulation of alternative splicing (Hayashi et al., 2014; Malone et al., 2014). Future work will therefore focus on attempts to identify specific Acn-dependent transcripts that may play a role in the regulation of autophagy or identifying alternative mechanisms for its role in the regulation of basal, starvation-independent autophagy.

Materials and methods

A key resources table can be found in Supplementary file 4.

Fly work

Flies were maintained using standard conditions. Bloomington Stock Center provided Da-Gal4, Arm-Gal4, GMR-Gal4 driver lines, w1118, the RNAi lines and human neurodegenerative disease model lines (BS lines: 33769, 8141, 33818, 51376, 33606, 8534). Other fly strains used were p38bΔ45, a null generated by transposon excision and removing most of the p38b coding region, UAS-p38b, UAS-p38bK53R (Vrailas-Mortimer et al., 2011); p3520C, which deletes ~90% of the p35 coding region, including all sequences required for binding to and activating Cdk5; (Connell-Crowley et al., 2007), UAS-p35, UAS-Cdk5, UAS-Cdk5K33A; (Connell-Crowley et al., 2000). A Cdk5 null allele and genomic rescue transgene (Kissler et al., 2009) were gifts from Edward Giniger, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland. UAS-Htt-exon1-Q93, (Steffan et al., 2001), abbreviated UAS-Htt.Q93, was a gift from Robin Hiesinger, Free University Berlin, Berlin, Germany. Transgenic flies were generated by BestGene, Inc. DNA constructs related to genomic acn were generated by standard mutagenesis of a 4 kb Acn DNA fragment sufficient for genomic rescue (Haberman et al., 2010), confirmed by sequencing, cloned into an Attb vector, and inserted into the 96F3 AttP landing site (Venken et al., 2006). Similarly, UAS-controlled wild-type and mutant Acn transgenes were generated by standard mutagenesis from full-length Acn cDNA, confirmed by sequencing, and inserted into pUAS vectors modified by addition of an AttB site (Nandi et al., 2014). Experiments with UAS-RNAi transgenes were performed at 28°C to maximize knockdown efficiency.

Starvation resistance and life span were analyzed as described previously (Nandi et al., 2014). Briefly, for starvation resistance 4- to 5-day-old virgins were kept in vials containing 1% agarose in 1X PBS at 25°C and dead flies are counted every 6 hr intervals. To measure life spans, males that emerged within a 2-day period were aged for an additional 3 days, kept in demographic cages and their survival at 25°C was recorded every other day.

Biochemistry

Antibodies against pS437-Acn was raised in rabbits by Genemed Synthesis against the Acn peptide H I V R D P- S(p)-P A R N R A S and double-affinity purified. For Western blots, five 96 hr larvae were crushed in 300 µl lysis buffer (10% SDS, 6 M urea, and 50 mM Tris-HCl, pH 6.8) at 95°C, boiled for 2 min, and spun for 10 min at 20,000xg. 20 µl lysate from larvae were separated by SDS-PAGE, transferred to nitrocellulose membranes, blocked in 3% non-fat dried milk and probed with mouse antibodies against Actin (JLA20) or Myc (9E10; both at 1:2,000; Developmental Studies Hybridoma Bank), guinea pig anti-Acn (aa 423–599, 1:3,000, Haberman et al., 2010). For Western blots with pS437-Acn antibodies, 1% BSA was used as blocking reagent. Using IR-dye labeled secondary antibodies and the Odyssey scanner (LI-COR Biosciences) bound antibodies were detected and quantified by comparison to Actin. Prestained molecular weight markers (HX Stable) were obtained from UBP-Bio.

Non-radioactive Cdk5 in vitro kinase assays were performed essentially as described (Hong and Guan, 2017). In brief, GST-Acn402-527 fusion proteins (WT or S437A mutant) were expressed in a 30-ml culture of BL21 bacteria and immobilized and purified on 10 µl glutathione sepharose beads using standard procedures (Hong and Guan, 2017). Alternatively, Streptag-2xMyc-tagged full-length Acinus proteins (WT or S437A) were expressed in S2 cells as described (Stenesen et al., 2015), immobilized and purified on Strep-Tactin magnetic beads (IBA) according to the manufacturer’s instructions.

Immobilized GST-Acn fusion proteins or Streptag-Myc-tagged Acn proteins were exposed to 10 or 30 ng Cdk5/p35 complex (Upstate (Sigma) 14–477) in 30 µl kinase assay buffer (25 mM MOPS, pH 7.2, 12. 5 mM glycerol 2-phos-phate, 25 mM MgCl2, 5 mM EGTA, 2 mM EDTA, 0.25 mM DTT, and 0.5 mM ATP) for 20 min at 30°C. Immobilized Acn proteins were washed twice with PBS containing 0.1% Triton-X100, eluted with 20 mM glutathione and analyzed by western blots using antibodies against Acinus (1:2000, Haberman et al., 2010) or pS437-Acn (1:2000).

Quantitative RT-PCR was used to measure transcript levels of Myc-tagged Acn transgenes and knockdown efficiencies as previously described (Akbar et al., 2011). In short, RNA was isolated using TRIZOL (Ambion) according to the manufacturer’s instructions. 2 µg RNA was reverse transcribed using High-Capacity cDNA Reverse Transcription kit (Applied Biosystems) using random hexamer primers. Quantitative PCR was performed using the Fast SYBR Green Master Mix in a real-time PCR system (Fast 7500; Applied Biosystems). Each data point was repeated three times and normalized for the message for ribosomal protein 49 (RP49).

Primers were:

Myc-left, 5′-CTGGAGGAGCAGAAGCTGAT-3′, within the Myc and

Acn_right, 5′-GGAGTCTCGACCTCGGTCTT-3′, within the Acn coding regions, and

RP49_left, 5′-ATCGGTTACGGATCGAACAA-3′, and

RP49_right, 5′-GACAATCTCCTTGCGCTTCT-3′.

Cdk5_left: 5’-AATGGAGAAGATCGGGGAGG-3’

Cdk5_right: 5’-GGGAGATCTGCC TGCTGA-3’

p38b_left: 5’-GACGCCGATCTGAACAACAT-3’

p38b_right: 5’-ATCCTGGATTTCGGTTTGGC-3’

p35_left: 5’-TGTTCTTGCACTGTCGTTGT-3’

p35_right: 5’-TCAGCGGAGAAGAGAGCAAG-3’

Histology

SEMs of fly eyes were obtained as previously described (Wolff, 2011). Briefly, eyes were fixed in 2% paraformaldehyde, 2% glutaraldehyde, 0.2% Tween 20, and 0.1 M cacodylate buffer, pH 7.4, for 2 hr. Fixed samples were washed for 12 hr each in a series of four washes with increasing ethanol (25–100%). This is followed by a series of hexamethyldisilazane washes (25–100% in ethanol) for 1 hr each. Flies air dried overnight were mounted on SEM stubs and coated in fast-drying silver paint on their bodies only. Flies were sputter coated with a gold/pallidum mixture for 90 s and imaged at 1000 × magnification, with extra high tension set at 3.0 kV on a scanning electron microscope (SIGMA; Carl Zeiss). The microscope was equipped with the InLens detector (Carl Zeiss).

For TEM, size-matched 96 hr fed larvae were dissected and processed as described earlier in Nandi et al. (2014). In short, dissected larvae were fixed in 2% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.2 and postfixed with 2% OsO4 and 1.5% KFeCN in the same buffer. Samples were embedded in epoxy resin, sectioned. Sections were stained with uranyl acetate and lead citrate to enhance contrast, examined with a transmission electron microscope (120 kV; Tecnai G2 Spirit BioTWIN; FEI), and images were captured with an 11-megapixel camera (Morada; Olympus). From TEMs, measurements of autolysosomal diameters and areas were obtained using Macnification software (Orbicule).

Immunofluorescence

Whole-mount tissues were prepared for immunofluorescence staining as previously described (Akbar et al., 2011). Briefly, dissected samples were fixed in periodate-lysine-paraformaldehyde, washed in PBS, permeabilized with 0.3% saponin in PBS (PBSS), blocked with 5% goat serum in PBSS, and stained with the indicated primary antibodies: guinea pig anti-Acn (1:1000, Haberman et al., 2010), mouse anti-Myc (9E10, 1:1000), mouse anti-FLAG (1:1000; Sigma), rabbit anti-p62 (1:2000, Pircs et al., 2012), a gift from G. Juhàsz (Eötvös Loránd University, Budapest, Hungary), rabbit anti-GABARAP (1:200; Abcam, ab109364), which detects endogenous Atg8a (Kim et al., 2015), mouse-anti 1C2 (1:1,000; MAB1574; EMD Millipore), rabbit anti-Boss (1:2000, Krämer et al., 1991), and secondary antibodies were labeled with Alexa Fluor 488, 568, or 647 (1:500; Molecular Probes) and mounted in Vectashield containing DAPI (Vector Laboratories). Fluorescence images were captured with 63×, NA 1.4 or 40×, NA1.3 Plan Apochromat lenses on an inverted confocal microscope (LSM 510 Meta or LSM 710; Carl Zeiss Jena). Confocal Z-stacks of eye discs were obtained at 1 µm step size.

For phosphatase treatment, dissected third instar larval carcasses were fixed in periodate-lysine-paraformaldehyde and treated with 130 U/ml Calf Intestinal Phosphatase (New England Biolabs, Inc.) for 3 hr at 37°C with 1X protease inhibitor tablet (Roche) dissolved in 1X PBS, pH 7.5. Subsequently, tissues were processed and stained, and eye disc mounted as described above. For autophagy flux experiments, 72-hr-old larvae were transferred to fresh medium containing 3 mg/ml chloroquine (Sigma) as described (Lőw et al., 2013).

LysoTracker staining (GFP-Certified Lyso-ID red lysosomal detection kit; Enzo Life Sciences) of size-matched 90–96 hr fat bodies from fed and starved larvae was performed as previously described (Rusten et al., 2004; Scott et al., 2004). In brief, larvae were dissected in Schneider’s Drosophila media (Gibco), inverted to expose fat bodies, and incubated in 100 µM LysoTracker Red DND-99 for 1 min. Inverted carcasses were then washed in 1X PBS and fat bodies were mounted onto a droplet of Vectashield (Vector Laboratories). Samples were imaged immediately on an inverted confocal microscope (LSM 510 Meta using 63×, NA 1.4 Plan Apochromat lens). Z-projections of three optical sections of fat body tissue, each 1 µm apart were used to quantify LysoTracker and Atg8a punctae in fat bodies using Imaris software (Bitplane). The number of punctate was quantified per fat body cell. Digital images for display were imported into Photoshop (Adobe) and adjusted for gain, contrast, and gamma settings.

Integrated intensities of Atg8a punctae in fat bodies were determined using Image J and normalized to AcnWT. Integrated densities for pS437-Acinus and polyQ in eye discs were quantified using Image J software. Identical areas posterior to the morphogenetic furrow were quantified, thereby excluding dividing cells close to the furrow that were strongly stained for pS437-Acinus.

All immunofluorescence experiments were repeated at least three times with at least three samples each.

Poly-Q dot blot filter retardation assay

Polyglutamine aggregates were detected with a modified filter assay (Scherzinger et al., 1997). Briefly, 25 heads from 2 week-old flies were homogenized in 200 µl Cytoplasmic Extraction Reagent I buffer and fractionated using NE-PER Nuclear and Cytoplasmic Extraction Reagents following the manufacturer’s protocol (Thermo Fisher Scientific). Cytosolic fractions were adjusted to 1% SDS, incubated at room temperature for 15 min, denatured at 95°C for 5 min, and filtered through a 0.2 µm cellulose acetate membrane (Sterlitech Corporation) preequilibrated with 1% SDS. Membrane was washed twice with 0.2% SDS and blocked in TBS (100 mM Tris-HCl, pH 7.4, and 150 mM NaCl) containing 3% nonfat dried milk and probed with a mouse anti-Htt antibody (1:1,000; MAB5490; EMD Millipore). The bound antibodies are detected and quantified using anti-IR dye conjugated secondary antibodies and Odyssey scanner and software (LI-COR Biosciences).

Statistical methods

Statistical significance was determined in Prism using log-rank for survival assays, chi square analysis for eye roughness frequencies, and one-way analysis of variance for multiple comparisons, followed by Tukey’s test. To separate effects of treatment and genetic background we used two-way analysis of variance for multiple comparisons, followed by Bonferroni’s test for individual comparisons. All bar graphs resulting from these analysis show means ±SD. For quantifications of fluorescence images and Western blots, at least three independent experiments were used. P values smaller than 0.05 are considered significant, and values are indicated with one (<0.05), two (<0.01), three (<0.001), or four (<0.0001) asterisks.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
    A decade of CDK5
    1. R Dhavan
    2. LH Tsai
    (2001)
    Nature Reviews Molecular Cell Biology 2:749–759.
    https://doi.org/10.1038/35096019
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
    Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
    1. DJ Klionsky
    2. K Abdelmohsen
    3. A Abe
    4. MJ Abedin
    5. H Abeliovich
    6. A Acevedo Arozena
    7. H Adachi
    8. CM Adams
    9. PD Adams
    10. K Adeli
    11. PJ Adhihetty
    12. SG Adler
    13. G Agam
    14. R Agarwal
    15. MK Aghi
    16. M Agnello
    17. P Agostinis
    18. PV Aguilar
    19. J Aguirre-Ghiso
    20. EM Airoldi
    21. S Ait-Si-Ali
    22. T Akematsu
    23. ET Akporiaye
    24. M Al-Rubeai
    25. GM Albaiceta
    26. C Albanese
    27. D Albani
    28. ML Albert
    29. J Aldudo
    30. H Algül
    31. M Alirezaei
    32. I Alloza
    33. A Almasan
    34. M Almonte-Beceril
    35. ES Alnemri
    36. C Alonso
    37. N Altan-Bonnet
    38. DC Altieri
    39. S Alvarez
    40. L Alvarez-Erviti
    41. S Alves
    42. G Amadoro
    43. A Amano
    44. C Amantini
    45. S Ambrosio
    46. I Amelio
    47. AO Amer
    48. M Amessou
    49. A Amon
    50. Z An
    51. FA Anania
    52. SU Andersen
    53. UP Andley
    54. CK Andreadi
    55. N Andrieu-Abadie
    56. A Anel
    57. DK Ann
    58. S Anoopkumar-Dukie
    59. M Antonioli
    60. H Aoki
    61. N Apostolova
    62. S Aquila
    63. K Aquilano
    64. K Araki
    65. E Arama
    66. A Aranda
    67. J Araya
    68. A Arcaro
    69. E Arias
    70. H Arimoto
    71. AR Ariosa
    72. JL Armstrong
    73. T Arnould
    74. I Arsov
    75. K Asanuma
    76. V Askanas
    77. E Asselin
    78. R Atarashi
    79. SS Atherton
    80. JD Atkin
    81. LD Attardi
    82. P Auberger
    83. G Auburger
    84. L Aurelian
    85. R Autelli
    86. L Avagliano
    87. ML Avantaggiati
    88. L Avrahami
    89. S Awale
    90. N Azad
    91. T Bachetti
    92. JM Backer
    93. DH Bae
    94. JS Bae
    95. ON Bae
    96. SH Bae
    97. EH Baehrecke
    98. SH Baek
    99. S Baghdiguian
    100. A Bagniewska-Zadworna
    101. H Bai
    102. J Bai
    103. XY Bai
    104. Y Bailly
    105. KN Balaji
    106. W Balduini
    107. A Ballabio
    108. R Balzan
    109. R Banerjee
    110. G Bánhegyi
    111. H Bao
    112. B Barbeau
    113. MD Barrachina
    114. E Barreiro
    115. B Bartel
    116. A Bartolomé
    117. DC Bassham
    118. MT Bassi
    119. RC Bast
    120. A Basu
    121. MT Batista
    122. H Batoko
    123. M Battino
    124. K Bauckman
    125. BL Baumgarner
    126. KU Bayer
    127. R Beale
    128. JF Beaulieu
    129. GR Beck
    130. C Becker
    131. JD Beckham
    132. PA Bédard
    133. PJ Bednarski
    134. TJ Begley
    135. C Behl
    136. C Behrends
    137. GM Behrens
    138. KE Behrns
    139. E Bejarano
    140. A Belaid
    141. F Belleudi
    142. G Bénard
    143. G Berchem
    144. D Bergamaschi
    145. M Bergami
    146. B Berkhout
    147. L Berliocchi
    148. A Bernard
    149. M Bernard
    150. F Bernassola
    151. A Bertolotti
    152. AS Bess
    153. S Besteiro
    154. S Bettuzzi
    155. S Bhalla
    156. S Bhattacharyya
    157. SK Bhutia
    158. C Biagosch
    159. MW Bianchi
    160. M Biard-Piechaczyk
    161. V Billes
    162. C Bincoletto
    163. B Bingol
    164. SW Bird
    165. M Bitoun
    166. I Bjedov
    167. C Blackstone
    168. L Blanc
    169. GA Blanco
    170. HK Blomhoff
    171. E Boada-Romero
    172. S Böckler
    173. M Boes
    174. K Boesze-Battaglia
    175. LH Boise
    176. A Bolino
    177. A Boman
    178. P Bonaldo
    179. M Bordi
    180. J Bosch
    181. LM Botana
    182. J Botti
    183. G Bou
    184. M Bouché
    185. M Bouchecareilh
    186. MJ Boucher
    187. ME Boulton
    188. SG Bouret
    189. P Boya
    190. M Boyer-Guittaut
    191. PV Bozhkov
    192. N Brady
    193. VM Braga
    194. C Brancolini
    195. GH Braus
    196. JM Bravo-San Pedro
    197. LA Brennan
    198. EH Bresnick
    199. P Brest
    200. D Bridges
    201. MA Bringer
    202. M Brini
    203. GC Brito
    204. B Brodin
    205. PS Brookes
    206. EJ Brown
    207. K Brown
    208. HE Broxmeyer
    209. A Bruhat
    210. PC Brum
    211. JH Brumell
    212. N Brunetti-Pierri
    213. RJ Bryson-Richardson
    214. S Buch
    215. AM Buchan
    216. H Budak
    217. DV Bulavin
    218. SJ Bultman
    219. G Bultynck
    220. V Bumbasirevic
    221. Y Burelle
    222. RE Burke
    223. M Burmeister
    224. P Bütikofer
    225. L Caberlotto
    226. K Cadwell
    227. M Cahova
    228. D Cai
    229. J Cai
    230. Q Cai
    231. S Calatayud
    232. N Camougrand
    233. M Campanella
    234. GR Campbell
    235. M Campbell
    236. S Campello
    237. R Candau
    238. I Caniggia
    239. L Cantoni
    240. L Cao
    241. AB Caplan
    242. M Caraglia
    243. C Cardinali
    244. SM Cardoso
    245. JS Carew
    246. LA Carleton
    247. CR Carlin
    248. S Carloni
    249. SR Carlsson
    250. D Carmona-Gutierrez
    251. LA Carneiro
    252. O Carnevali
    253. S Carra
    254. A Carrier
    255. B Carroll
    256. C Casas
    257. J Casas
    258. G Cassinelli
    259. P Castets
    260. S Castro-Obregon
    261. G Cavallini
    262. I Ceccherini
    263. F Cecconi
    264. AI Cederbaum
    265. V Ceña
    266. S Cenci
    267. C Cerella
    268. D Cervia
    269. S Cetrullo
    270. H Chaachouay
    271. HJ Chae
    272. AS Chagin
    273. CY Chai
    274. G Chakrabarti
    275. G Chamilos
    276. EY Chan
    277. MT Chan
    278. D Chandra
    279. P Chandra
    280. CP Chang
    281. RC Chang
    282. TY Chang
    283. JC Chatham
    284. S Chatterjee
    285. S Chauhan
    286. Y Che
    287. ME Cheetham
    288. R Cheluvappa
    289. CJ Chen
    290. G Chen
    291. GC Chen
    292. G Chen
    293. H Chen
    294. JW Chen
    295. JK Chen
    296. M Chen
    297. M Chen
    298. P Chen
    299. Q Chen
    300. Q Chen
    301. SD Chen
    302. S Chen
    303. SS Chen
    304. W Chen
    305. WJ Chen
    306. WQ Chen
    307. W Chen
    308. X Chen
    309. YH Chen
    310. YG Chen
    311. Y Chen
    312. Y Chen
    313. Y Chen
    314. YJ Chen
    315. YQ Chen
    316. Y Chen
    317. Z Chen
    318. Z Chen
    319. A Cheng
    320. CH Cheng
    321. H Cheng
    322. H Cheong
    323. S Cherry
    324. J Chesney
    325. CH Cheung
    326. E Chevet
    327. HC Chi
    328. SG Chi
    329. F Chiacchiera
    330. HL Chiang
    331. R Chiarelli
    332. M Chiariello
    333. M Chieppa
    334. LS Chin
    335. M Chiong
    336. GN Chiu
    337. DH Cho
    338. SG Cho
    339. WC Cho
    340. YY Cho
    341. YS Cho
    342. AM Choi
    343. EJ Choi
    344. EK Choi
    345. J Choi
    346. ME Choi
    347. SI Choi
    348. TF Chou
    349. S Chouaib
    350. D Choubey
    351. V Choubey
    352. KC Chow
    353. K Chowdhury
    354. CT Chu
    355. TH Chuang
    356. T Chun
    357. H Chung
    358. T Chung
    359. YL Chung
    360. YJ Chwae
    361. V Cianfanelli
    362. R Ciarcia
    363. IA Ciechomska
    364. MR Ciriolo
    365. M Cirone
    366. S Claerhout
    367. MJ Clague
    368. J Clària
    369. PG Clarke
    370. R Clarke
    371. E Clementi
    372. C Cleyrat
    373. M Cnop
    374. EM Coccia
    375. T Cocco
    376. P Codogno
    377. J Coers
    378. EE Cohen
    379. D Colecchia
    380. L Coletto
    381. NS Coll
    382. E Colucci-Guyon
    383. S Comincini
    384. M Condello
    385. KL Cook
    386. GH Coombs
    387. CD Cooper
    388. JM Cooper
    389. I Coppens
    390. MT Corasaniti
    391. M Corazzari
    392. R Corbalan
    393. E Corcelle-Termeau
    394. MD Cordero
    395. C Corral-Ramos
    396. O Corti
    397. A Cossarizza
    398. P Costelli
    399. S Costes
    400. SL Cotman
    401. A Coto-Montes
    402. S Cottet
    403. E Couve
    404. LR Covey
    405. LA Cowart
    406. JS Cox
    407. FP Coxon
    408. CB Coyne
    409. MS Cragg
    410. RJ Craven
    411. T Crepaldi
    412. JL Crespo
    413. A Criollo
    414. V Crippa
    415. MT Cruz
    416. AM Cuervo
    417. JM Cuezva
    418. T Cui
    419. PR Cutillas
    420. MJ Czaja
    421. MF Czyzyk-Krzeska
    422. RK Dagda
    423. U Dahmen
    424. C Dai
    425. W Dai
    426. Y Dai
    427. KN Dalby
    428. L Dalla Valle
    429. G Dalmasso
    430. M D'Amelio
    431. M Damme
    432. A Darfeuille-Michaud
    433. C Dargemont
    434. VM Darley-Usmar
    435. S Dasarathy
    436. B Dasgupta
    437. S Dash
    438. CR Dass
    439. HM Davey
    440. LM Davids
    441. D Dávila
    442. RJ Davis
    443. TM Dawson
    444. VL Dawson
    445. P Daza
    446. J de Belleroche
    447. P de Figueiredo
    448. RC de Figueiredo
    449. J de la Fuente
    450. L De Martino
    451. A De Matteis
    452. GR De Meyer
    453. A De Milito
    454. M De Santi
    455. W de Souza
    456. V De Tata
    457. D De Zio
    458. J Debnath
    459. R Dechant
    460. JP Decuypere
    461. S Deegan
    462. B Dehay
    463. B Del Bello
    464. DP Del Re
    465. R Delage-Mourroux
    466. LM Delbridge
    467. L Deldicque
    468. E Delorme-Axford
    469. Y Deng
    470. J Dengjel
    471. M Denizot
    472. P Dent
    473. CJ Der
    474. V Deretic
    475. B Derrien
    476. E Deutsch
    477. TP Devarenne
    478. RJ Devenish
    479. S Di Bartolomeo
    480. N Di Daniele
    481. F Di Domenico
    482. A Di Nardo
    483. S Di Paola
    484. A Di Pietro
    485. L Di Renzo
    486. A DiAntonio
    487. G Díaz-Araya
    488. I Díaz-Laviada
    489. MT Diaz-Meco
    490. J Diaz-Nido
    491. CA Dickey
    492. RC Dickson
    493. M Diederich
    494. P Digard
    495. I Dikic
    496. SP Dinesh-Kumar
    497. C Ding
    498. WX Ding
    499. Z Ding
    500. L Dini
    501. JH Distler
    502. A Diwan
    503. M Djavaheri-Mergny
    504. K Dmytruk
    505. RC Dobson
    506. V Doetsch
    507. K Dokladny
    508. S Dokudovskaya
    509. M Donadelli
    510. XC Dong
    511. X Dong
    512. Z Dong
    513. TM Donohue
    514. KS Doran
    515. G D'Orazi
    516. GW Dorn
    517. V Dosenko
    518. S Dridi
    519. L Drucker
    520. J Du
    521. LL Du
    522. L Du
    523. A du Toit
    524. P Dua
    525. L Duan
    526. P Duann
    527. VK Dubey
    528. MR Duchen
    529. MA Duchosal
    530. H Duez
    531. I Dugail
    532. VI Dumit
    533. MC Duncan
    534. EA Dunlop
    535. WA Dunn
    536. N Dupont
    537. L Dupuis
    538. RV Durán
    539. TM Durcan
    540. S Duvezin-Caubet
    541. U Duvvuri
    542. V Eapen
    543. D Ebrahimi-Fakhari
    544. A Echard
    545. L Eckhart
    546. CL Edelstein
    547. AL Edinger
    548. L Eichinger
    549. T Eisenberg
    550. A Eisenberg-Lerner
    551. NT Eissa
    552. WS El-Deiry
    553. V El-Khoury
    554. Z Elazar
    555. H Eldar-Finkelman
    556. CJ Elliott
    557. E Emanuele
    558. U Emmenegger
    559. N Engedal
    560. AM Engelbrecht
    561. S Engelender
    562. JM Enserink
    563. R Erdmann
    564. J Erenpreisa
    565. R Eri
    566. JL Eriksen
    567. A Erman
    568. R Escalante
    569. EL Eskelinen
    570. L Espert
    571. L Esteban-Martínez
    572. TJ Evans
    573. M Fabri
    574. G Fabrias
    575. C Fabrizi
    576. A Facchiano
    577. NJ Færgeman
    578. A Faggioni
    579. WD Fairlie
    580. C Fan
    581. D Fan
    582. J Fan
    583. S Fang
    584. M Fanto
    585. A Fanzani
    586. T Farkas
    587. M Faure
    588. FB Favier
    589. H Fearnhead
    590. M Federici
    591. E Fei
    592. TC Felizardo
    593. H Feng
    594. Y Feng
    595. Y Feng
    596. TA Ferguson
    597. ÁF Fernández
    598. MG Fernandez-Barrena
    599. JC Fernandez-Checa
    600. A Fernández-López
    601. ME Fernandez-Zapico
    602. O Feron
    603. E Ferraro
    604. CV Ferreira-Halder
    605. L Fesus
    606. R Feuer
    607. FC Fiesel
    608. EC Filippi-Chiela
    609. G Filomeni
    610. GM Fimia
    611. JH Fingert
    612. S Finkbeiner
    613. T Finkel
    614. F Fiorito
    615. PB Fisher
    616. M Flajolet
    617. F Flamigni
    618. O Florey
    619. S Florio
    620. RA Floto
    621. M Folini
    622. C Follo
    623. EA Fon
    624. F Fornai
    625. F Fortunato
    626. A Fraldi
    627. R Franco
    628. A Francois
    629. A François
    630. LB Frankel
    631. ID Fraser
    632. N Frey
    633. DG Freyssenet
    634. C Frezza
    635. SL Friedman
    636. DE Frigo
    637. D Fu
    638. JM Fuentes
    639. J Fueyo
    640. Y Fujitani
    641. Y Fujiwara
    642. M Fujiya
    643. M Fukuda
    644. S Fulda
    645. C Fusco
    646. B Gabryel
    647. M Gaestel
    648. P Gailly
    649. M Gajewska
    650. S Galadari
    651. G Galili
    652. I Galindo
    653. MF Galindo
    654. G Galliciotti
    655. L Galluzzi
    656. L Galluzzi
    657. V Galy
    658. N Gammoh
    659. S Gandy
    660. AK Ganesan
    661. S Ganesan
    662. IG Ganley
    663. M Gannagé
    664. FB Gao
    665. F Gao
    666. JX Gao
    667. L García Nannig
    668. E García Véscovi
    669. M Garcia-Macía
    670. C Garcia-Ruiz
    671. AD Garg
    672. PK Garg
    673. R Gargini
    674. NC Gassen
    675. D Gatica
    676. E Gatti
    677. J Gavard
    678. E Gavathiotis
    679. L Ge
    680. P Ge
    681. S Ge
    682. PW Gean
    683. V Gelmetti
    684. AA Genazzani
    685. J Geng
    686. P Genschik
    687. L Gerner
    688. JE Gestwicki
    689. DA Gewirtz
    690. S Ghavami
    691. E Ghigo
    692. D Ghosh
    693. AM Giammarioli
    694. F Giampieri
    695. C Giampietri
    696. A Giatromanolaki
    697. DJ Gibbings
    698. L Gibellini
    699. SB Gibson
    700. V Ginet
    701. A Giordano
    702. F Giorgini
    703. E Giovannetti
    704. SE Girardin
    705. S Gispert
    706. S Giuliano
    707. CL Gladson
    708. A Glavic
    709. M Gleave
    710. N Godefroy
    711. RM Gogal
    712. K Gokulan
    713. GH Goldman
    714. D Goletti
    715. MS Goligorsky
    716. AV Gomes
    717. LC Gomes
    718. H Gomez
    719. C Gomez-Manzano
    720. R Gómez-Sánchez
    721. DA Gonçalves
    722. E Goncu
    723. Q Gong
    724. C Gongora
    725. CB Gonzalez
    726. P Gonzalez-Alegre
    727. P Gonzalez-Cabo
    728. RA González-Polo
    729. IS Goping
    730. C Gorbea
    731. NV Gorbunov
    732. DR Goring
    733. AM Gorman
    734. SM Gorski
    735. S Goruppi
    736. S Goto-Yamada
    737. C Gotor
    738. RA Gottlieb
    739. I Gozes
    740. D Gozuacik
    741. Y Graba
    742. M Graef
    743. GE Granato
    744. GD Grant
    745. S Grant
    746. GL Gravina
    747. DR Green
    748. A Greenhough
    749. MT Greenwood
    750. B Grimaldi
    751. F Gros
    752. C Grose
    753. JF Groulx
    754. F Gruber
    755. P Grumati
    756. T Grune
    757. JL Guan
    758. KL Guan
    759. B Guerra
    760. C Guillen
    761. K Gulshan
    762. J Gunst
    763. C Guo
    764. L Guo
    765. M Guo
    766. W Guo
    767. XG Guo
    768. AA Gust
    769. ÅB Gustafsson
    770. E Gutierrez
    771. MG Gutierrez
    772. HS Gwak
    773. A Haas
    774. JE Haber
    775. S Hadano
    776. M Hagedorn
    777. DR Hahn
    778. AJ Halayko
    779. A Hamacher-Brady
    780. K Hamada
    781. A Hamai
    782. A Hamann
    783. M Hamasaki
    784. I Hamer
    785. Q Hamid
    786. EM Hammond
    787. F Han
    788. W Han
    789. JT Handa
    790. JA Hanover
    791. M Hansen
    792. M Harada
    793. L Harhaji-Trajkovic
    794. JW Harper
    795. AH Harrath
    796. AL Harris
    797. J Harris
    798. U Hasler
    799. P Hasselblatt
    800. K Hasui
    801. RG Hawley
    802. TS Hawley
    803. C He
    804. CY He
    805. F He
    806. G He
    807. RR He
    808. XH He
    809. YW He
    810. YY He
    811. JK Heath
    812. MJ Hébert
    813. RA Heinzen
    814. GV Helgason
    815. M Hensel
    816. EP Henske
    817. C Her
    818. PK Herman
    819. A Hernández
    820. C Hernandez
    821. S Hernández-Tiedra
    822. C Hetz
    823. PR Hiesinger
    824. K Higaki
    825. S Hilfiker
    826. BG Hill
    827. JA Hill
    828. WD Hill
    829. K Hino
    830. D Hofius
    831. P Hofman
    832. GU Höglinger
    833. J Höhfeld
    834. MK Holz
    835. Y Hong
    836. DA Hood
    837. JJ Hoozemans
    838. T Hoppe
    839. C Hsu
    840. CY Hsu
    841. LC Hsu
    842. D Hu
    843. G Hu
    844. HM Hu
    845. H Hu
    846. MC Hu
    847. YC Hu
    848. ZW Hu
    849. F Hua
    850. Y Hua
    851. C Huang
    852. HL Huang
    853. KH Huang
    854. KY Huang
    855. S Huang
    856. S Huang
    857. WP Huang
    858. YR Huang
    859. Y Huang
    860. Y Huang
    861. TB Huber
    862. P Huebbe
    863. WK Huh
    864. JJ Hulmi
    865. GM Hur
    866. JH Hurley
    867. Z Husak
    868. SN Hussain
    869. S Hussain
    870. JJ Hwang
    871. S Hwang
    872. TI Hwang
    873. A Ichihara
    874. Y Imai
    875. C Imbriano
    876. M Inomata
    877. T Into
    878. V Iovane
    879. JL Iovanna
    880. RV Iozzo
    881. NY Ip
    882. JE Irazoqui
    883. P Iribarren
    884. Y Isaka
    885. AJ Isakovic
    886. H Ischiropoulos
    887. JS Isenberg
    888. M Ishaq
    889. H Ishida
    890. I Ishii
    891. JE Ishmael
    892. C Isidoro
    893. K Isobe
    894. E Isono
    895. S Issazadeh-Navikas
    896. K Itahana
    897. E Itakura
    898. AI Ivanov
    899. AK Iyer
    900. JM Izquierdo
    901. Y Izumi
    902. V Izzo
    903. M Jäättelä
    904. N Jaber
    905. DJ Jackson
    906. WT Jackson
    907. TG Jacob
    908. TS Jacques
    909. C Jagannath
    910. A Jain
    911. NR Jana
    912. BK Jang
    913. A Jani
    914. B Janji
    915. PR Jannig
    916. PJ Jansson
    917. S Jean
    918. M Jendrach
    919. JH Jeon
    920. N Jessen
    921. EB Jeung
    922. K Jia
    923. L Jia
    924. H Jiang
    925. H Jiang
    926. L Jiang
    927. T Jiang
    928. X Jiang
    929. X Jiang
    930. X Jiang
    931. Y Jiang
    932. Y Jiang
    933. A Jiménez
    934. C Jin
    935. H Jin
    936. L Jin
    937. M Jin
    938. S Jin
    939. UK Jinwal
    940. EK Jo
    941. T Johansen
    942. DE Johnson
    943. GV Johnson
    944. JD Johnson
    945. E Jonasch
    946. C Jones
    947. LA Joosten
    948. J Jordan
    949. AM Joseph
    950. B Joseph
    951. AM Joubert
    952. D Ju
    953. J Ju
    954. HF Juan
    955. K Juenemann
    956. G Juhász
    957. HS Jung
    958. JU Jung
    959. YK Jung
    960. H Jungbluth
    961. MJ Justice
    962. B Jutten
    963. NO Kaakoush
    964. K Kaarniranta
    965. A Kaasik
    966. T Kabuta
    967. B Kaeffer
    968. K Kågedal
    969. A Kahana
    970. S Kajimura
    971. O Kakhlon
    972. M Kalia
    973. DV Kalvakolanu
    974. Y Kamada
    975. K Kambas
    976. VO Kaminskyy
    977. HH Kampinga
    978. M Kandouz
    979. C Kang
    980. R Kang
    981. TC Kang
    982. T Kanki
    983. TD Kanneganti
    984. H Kanno
    985. AG Kanthasamy
    986. M Kantorow
    987. M Kaparakis-Liaskos
    988. O Kapuy
    989. V Karantza
    990. MR Karim
    991. P Karmakar
    992. A Kaser
    993. S Kaushik
    994. T Kawula
    995. AM Kaynar
    996. PY Ke
    997. ZJ Ke
    998. JH Kehrl
    999. KE Keller
    1000. JK Kemper
    1001. AK Kenworthy
    1002. O Kepp
    1003. A Kern
    1004. S Kesari
    1005. D Kessel
    1006. R Ketteler
    1007. IC Kettelhut
    1008. B Khambu
    1009. MM Khan
    1010. VK Khandelwal
    1011. S Khare
    1012. JG Kiang
    1013. AA Kiger
    1014. A Kihara
    1015. AL Kim
    1016. CH Kim
    1017. DR Kim
    1018. DH Kim
    1019. EK Kim
    1020. HY Kim
    1021. HR Kim
    1022. JS Kim
    1023. JH Kim
    1024. JC Kim
    1025. JH Kim
    1026. KW Kim
    1027. MD Kim
    1028. MM Kim
    1029. PK Kim
    1030. SW Kim
    1031. SY Kim
    1032. YS Kim
    1033. Y Kim
    1034. A Kimchi
    1035. AC Kimmelman
    1036. T Kimura
    1037. JS King
    1038. K Kirkegaard
    1039. V Kirkin
    1040. LA Kirshenbaum
    1041. S Kishi
    1042. Y Kitajima
    1043. K Kitamoto
    1044. Y Kitaoka
    1045. K Kitazato
    1046. RA Kley
    1047. WT Klimecki
    1048. M Klinkenberg
    1049. J Klucken
    1050. H Knævelsrud
    1051. E Knecht
    1052. L Knuppertz
    1053. JL Ko
    1054. S Kobayashi
    1055. JC Koch
    1056. C Koechlin-Ramonatxo
    1057. U Koenig
    1058. YH Koh
    1059. K Köhler
    1060. SD Kohlwein
    1061. M Koike
    1062. M Komatsu
    1063. E Kominami
    1064. D Kong
    1065. HJ Kong
    1066. EG Konstantakou
    1067. BT Kopp
    1068. T Korcsmaros
    1069. L Korhonen
    1070. VI Korolchuk
    1071. NV Koshkina
    1072. Y Kou
    1073. MI Koukourakis
    1074. C Koumenis
    1075. AL Kovács
    1076. T Kovács
    1077. WJ Kovacs
    1078. D Koya
    1079. C Kraft
    1080. D Krainc
    1081. H Kramer
    1082. T Kravic-Stevovic
    1083. W Krek
    1084. C Kretz-Remy
    1085. R Krick
    1086. M Krishnamurthy
    1087. J Kriston-Vizi
    1088. G Kroemer
    1089. MC Kruer
    1090. R Kruger
    1091. NT Ktistakis
    1092. K Kuchitsu
    1093. C Kuhn
    1094. AP Kumar
    1095. A Kumar
    1096. A Kumar
    1097. D Kumar
    1098. D Kumar
    1099. R Kumar
    1100. S Kumar
    1101. M Kundu
    1102. HJ Kung
    1103. A Kuno
    1104. SH Kuo
    1105. J Kuret
    1106. T Kurz
    1107. T Kwok
    1108. TK Kwon
    1109. YT Kwon
    1110. I Kyrmizi
    1111. AR La Spada
    1112. F Lafont
    1113. T Lahm
    1114. A Lakkaraju
    1115. T Lam
    1116. T Lamark
    1117. S Lancel
    1118. TH Landowski
    1119. DJ Lane
    1120. JD Lane
    1121. C Lanzi
    1122. P Lapaquette
    1123. LR Lapierre
    1124. J Laporte
    1125. J Laukkarinen
    1126. GW Laurie
    1127. S Lavandero
    1128. L Lavie
    1129. MJ LaVoie
    1130. BY Law
    1131. HK Law
    1132. KB Law
    1133. R Layfield
    1134. PA Lazo
    1135. L Le Cam
    1136. KG Le Roch
    1137. H Le Stunff
    1138. V Leardkamolkarn
    1139. M Lecuit
    1140. BH Lee
    1141. CH Lee
    1142. EF Lee
    1143. GM Lee
    1144. HJ Lee
    1145. H Lee
    1146. JK Lee
    1147. J Lee
    1148. JH Lee
    1149. JH Lee
    1150. M Lee
    1151. MS Lee
    1152. PJ Lee
    1153. SW Lee
    1154. SJ Lee
    1155. SJ Lee
    1156. SY Lee
    1157. SH Lee
    1158. SS Lee
    1159. SJ Lee
    1160. S Lee
    1161. YR Lee
    1162. YJ Lee
    1163. YH Lee
    1164. C Leeuwenburgh
    1165. S Lefort
    1166. R Legouis
    1167. J Lei
    1168. QY Lei
    1169. DA Leib
    1170. G Leibowitz
    1171. I Lekli
    1172. SD Lemaire
    1173. JJ Lemasters
    1174. MK Lemberg
    1175. A Lemoine
    1176. S Leng
    1177. G Lenz
    1178. P Lenzi
    1179. LO Lerman
    1180. D Lettieri Barbato
    1181. JI Leu
    1182. HY Leung
    1183. B Levine
    1184. PA Lewis
    1185. F Lezoualc'h
    1186. C Li
    1187. F Li
    1188. FJ Li
    1189. J Li
    1190. K Li
    1191. L Li
    1192. M Li
    1193. M Li
    1194. Q Li
    1195. R Li
    1196. S Li
    1197. W Li
    1198. W Li
    1199. X Li
    1200. Y Li
    1201. J Lian
    1202. C Liang
    1203. Q Liang
    1204. Y Liao
    1205. J Liberal
    1206. PP Liberski
    1207. P Lie
    1208. AP Lieberman
    1209. HJ Lim
    1210. KL Lim
    1211. K Lim
    1212. RT Lima
    1213. CS Lin
    1214. CF Lin
    1215. F Lin
    1216. F Lin
    1217. FC Lin
    1218. K Lin
    1219. KH Lin
    1220. PH Lin
    1221. T Lin
    1222. WW Lin
    1223. YS Lin
    1224. Y Lin
    1225. R Linden
    1226. D Lindholm
    1227. LM Lindqvist
    1228. P Lingor
    1229. A Linkermann
    1230. LA Liotta
    1231. MM Lipinski
    1232. VA Lira
    1233. MP Lisanti
    1234. PB Liton
    1235. B Liu
    1236. C Liu
    1237. CF Liu
    1238. F Liu
    1239. HJ Liu
    1240. J Liu
    1241. JJ Liu
    1242. JL Liu
    1243. K Liu
    1244. L Liu
    1245. L Liu
    1246. Q Liu
    1247. RY Liu
    1248. S Liu
    1249. S Liu
    1250. W Liu
    1251. XD Liu
    1252. X Liu
    1253. XH Liu
    1254. X Liu
    1255. X Liu
    1256. X Liu
    1257. Y Liu
    1258. Y Liu
    1259. Z Liu
    1260. Z Liu
    1261. JP Liuzzi
    1262. G Lizard
    1263. M Ljujic
    1264. IJ Lodhi
    1265. SE Logue
    1266. BL Lokeshwar
    1267. YC Long
    1268. S Lonial
    1269. B Loos
    1270. C López-Otín
    1271. C López-Vicario
    1272. M Lorente
    1273. PL Lorenzi
    1274. P Lõrincz
    1275. M Los
    1276. MT Lotze
    1277. PE Lovat
    1278. B Lu
    1279. B Lu
    1280. J Lu
    1281. Q Lu
    1282. SM Lu
    1283. S Lu
    1284. Y Lu
    1285. F Luciano
    1286. S Luckhart
    1287. JM Lucocq
    1288. P Ludovico
    1289. A Lugea
    1290. NW Lukacs
    1291. JJ Lum
    1292. AH Lund
    1293. H Luo
    1294. J Luo
    1295. S Luo
    1296. C Luparello
    1297. T Lyons
    1298. J Ma
    1299. Y Ma
    1300. Y Ma
    1301. Z Ma
    1302. J Machado
    1303. GM Machado-Santelli
    1304. F Macian
    1305. GC MacIntosh
    1306. JP MacKeigan
    1307. KF Macleod
    1308. JD MacMicking
    1309. LA MacMillan-Crow
    1310. F Madeo
    1311. M Madesh
    1312. J Madrigal-Matute
    1313. A Maeda
    1314. T Maeda
    1315. G Maegawa
    1316. E Maellaro
    1317. H Maes
    1318. M Magariños
    1319. K Maiese
    1320. TK Maiti
    1321. L Maiuri
    1322. MC Maiuri
    1323. CG Maki
    1324. R Malli
    1325. W Malorni
    1326. A Maloyan
    1327. F Mami-Chouaib
    1328. N Man
    1329. JD Mancias
    1330. EM Mandelkow
    1331. MA Mandell
    1332. AA Manfredi
    1333. SN Manié
    1334. C Manzoni
    1335. K Mao
    1336. Z Mao
    1337. ZW Mao
    1338. P Marambaud
    1339. AM Marconi
    1340. Z Marelja
    1341. G Marfe
    1342. M Margeta
    1343. E Margittai
    1344. M Mari
    1345. FV Mariani
    1346. C Marin
    1347. S Marinelli
    1348. G Mariño
    1349. I Markovic
    1350. R Marquez
    1351. AM Martelli
    1352. S Martens
    1353. KR Martin
    1354. SJ Martin
    1355. S Martin
    1356. MA Martin-Acebes
    1357. P Martín-Sanz
    1358. C Martinand-Mari
    1359. W Martinet
    1360. J Martinez
    1361. N Martinez-Lopez
    1362. U Martinez-Outschoorn
    1363. M Martínez-Velázquez
    1364. M Martinez-Vicente
    1365. WK Martins
    1366. H Mashima
    1367. JA Mastrianni
    1368. G Matarese
    1369. P Matarrese
    1370. R Mateo
    1371. S Matoba
    1372. N Matsumoto
    1373. T Matsushita
    1374. A Matsuura
    1375. T Matsuzawa
    1376. MP Mattson
    1377. S Matus
    1378. N Maugeri
    1379. C Mauvezin
    1380. A Mayer
    1381. D Maysinger
    1382. GD Mazzolini
    1383. MK McBrayer
    1384. K McCall
    1385. C McCormick
    1386. GM McInerney
    1387. SC McIver
    1388. S McKenna
    1389. JJ McMahon
    1390. IA McNeish
    1391. F Mechta-Grigoriou
    1392. JP Medema
    1393. DL Medina
    1394. K Megyeri
    1395. M Mehrpour
    1396. JL Mehta
    1397. Y Mei
    1398. UC Meier
    1399. AJ Meijer
    1400. A Meléndez
    1401. G Melino
    1402. S Melino
    1403. EJ de Melo
    1404. MA Mena
    1405. MD Meneghini
    1406. JA Menendez
    1407. R Menezes
    1408. L Meng
    1409. LH Meng
    1410. S Meng
    1411. R Menghini
    1412. AS Menko
    1413. RF Menna-Barreto
    1414. MB Menon
    1415. MA Meraz-Ríos
    1416. G Merla
    1417. L Merlini
    1418. AM Merlot
    1419. A Meryk
    1420. S Meschini
    1421. JN Meyer
    1422. MT Mi
    1423. CY Miao
    1424. L Micale
    1425. S Michaeli
    1426. C Michiels
    1427. AR Migliaccio
    1428. AS Mihailidou
    1429. D Mijaljica
    1430. K Mikoshiba
    1431. E Milan
    1432. L Miller-Fleming
    1433. GB Mills
    1434. IG Mills
    1435. G Minakaki
    1436. BA Minassian
    1437. XF Ming
    1438. F Minibayeva
    1439. EA Minina
    1440. JD Mintern
    1441. S Minucci
    1442. A Miranda-Vizuete
    1443. CH Mitchell
    1444. S Miyamoto
    1445. K Miyazawa
    1446. N Mizushima
    1447. K Mnich
    1448. B Mograbi
    1449. S Mohseni
    1450. LF Moita
    1451. M Molinari
    1452. M Molinari
    1453. AB Møller
    1454. B Mollereau
    1455. F Mollinedo
    1456. M Mongillo
    1457. MM Monick
    1458. S Montagnaro
    1459. C Montell
    1460. DJ Moore
    1461. MN Moore
    1462. R Mora-Rodriguez
    1463. PI Moreira
    1464. E Morel
    1465. MB Morelli
    1466. S Moreno
    1467. MJ Morgan
    1468. A Moris
    1469. Y Moriyasu
    1470. JL Morrison
    1471. LA Morrison
    1472. E Morselli
    1473. J Moscat
    1474. PL Moseley
    1475. S Mostowy
    1476. E Motori
    1477. D Mottet
    1478. JC Mottram
    1479. CE Moussa
    1480. VE Mpakou
    1481. H Mukhtar
    1482. JM Mulcahy Levy
    1483. S Muller
    1484. R Muñoz-Moreno
    1485. C Muñoz-Pinedo
    1486. C Münz
    1487. ME Murphy
    1488. JT Murray
    1489. A Murthy
    1490. IU Mysorekar
    1491. IR Nabi
    1492. M Nabissi
    1493. GA Nader
    1494. Y Nagahara
    1495. Y Nagai
    1496. K Nagata
    1497. A Nagelkerke
    1498. P Nagy
    1499. SR Naidu
    1500. S Nair
    1501. H Nakano
    1502. H Nakatogawa
    1503. M Nanjundan
    1504. G Napolitano
    1505. NI Naqvi
    1506. R Nardacci
    1507. DP Narendra
    1508. M Narita
    1509. AC Nascimbeni
    1510. R Natarajan
    1511. LC Navegantes
    1512. ST Nawrocki
    1513. TY Nazarko
    1514. VY Nazarko
    1515. T Neill
    1516. LM Neri
    1517. MG Netea
    1518. RT Netea-Maier
    1519. BM Neves
    1520. PA Ney
    1521. IP Nezis
    1522. HT Nguyen
    1523. HP Nguyen
    1524. AS Nicot
    1525. H Nilsen
    1526. P Nilsson
    1527. M Nishimura
    1528. I Nishino
    1529. M Niso-Santano
    1530. H Niu
    1531. RA Nixon
    1532. VC Njar
    1533. T Noda
    1534. AA Noegel
    1535. EM Nolte
    1536. E Norberg
    1537. KK Norga
    1538. SK Noureini
    1539. S Notomi
    1540. L Notterpek
    1541. K Nowikovsky
    1542. N Nukina
    1543. T Nürnberger
    1544. VB O'Donnell
    1545. T O'Donovan
    1546. PJ O'Dwyer
    1547. I Oehme
    1548. CL Oeste
    1549. M Ogawa
    1550. B Ogretmen
    1551. Y Ogura
    1552. YJ Oh
    1553. M Ohmuraya
    1554. T Ohshima
    1555. R Ojha
    1556. K Okamoto
    1557. T Okazaki
    1558. FJ Oliver
    1559. K Ollinger
    1560. S Olsson
    1561. DP Orban
    1562. P Ordonez
    1563. I Orhon
    1564. L Orosz
    1565. EJ O'Rourke
    1566. H Orozco
    1567. AL Ortega
    1568. E Ortona
    1569. LD Osellame
    1570. J Oshima
    1571. S Oshima
    1572. HD Osiewacz
    1573. T Otomo
    1574. K Otsu
    1575. JH Ou
    1576. TF Outeiro
    1577. DY Ouyang
    1578. H Ouyang
    1579. M Overholtzer
    1580. MA Ozbun
    1581. PH Ozdinler
    1582. B Ozpolat
    1583. C Pacelli
    1584. P Paganetti
    1585. G Page
    1586. G Pages
    1587. U Pagnini
    1588. B Pajak
    1589. SC Pak
    1590. K Pakos-Zebrucka
    1591. N Pakpour
    1592. Z Palková
    1593. F Palladino
    1594. K Pallauf
    1595. N Pallet
    1596. M Palmieri
    1597. SR Paludan
    1598. C Palumbo
    1599. S Palumbo
    1600. O Pampliega
    1601. H Pan
    1602. W Pan
    1603. T Panaretakis
    1604. A Pandey
    1605. A Pantazopoulou
    1606. Z Papackova
    1607. DL Papademetrio
    1608. I Papassideri
    1609. A Papini
    1610. N Parajuli
    1611. J Pardo
    1612. VV Parekh
    1613. G Parenti
    1614. JI Park
    1615. J Park
    1616. OK Park
    1617. R Parker
    1618. R Parlato
    1619. JB Parys
    1620. KR Parzych
    1621. JM Pasquet
    1622. B Pasquier
    1623. KB Pasumarthi
    1624. D Patschan
    1625. C Patterson
    1626. S Pattingre
    1627. S Pattison
    1628. A Pause
    1629. H Pavenstädt
    1630. F Pavone
    1631. Z Pedrozo
    1632. FJ Peña
    1633. MA Peñalva
    1634. M Pende
    1635. J Peng
    1636. F Penna
    1637. JM Penninger
    1638. A Pensalfini
    1639. S Pepe
    1640. GJ Pereira
    1641. PC Pereira
    1642. V Pérez-de la Cruz
    1643. ME Pérez-Pérez
    1644. D Pérez-Rodríguez
    1645. D Pérez-Sala
    1646. C Perier
    1647. A Perl
    1648. DH Perlmutter
    1649. I Perrotta
    1650. S Pervaiz
    1651. M Pesonen
    1652. JE Pessin
    1653. GJ Peters
    1654. M Petersen
    1655. I Petrache
    1656. BJ Petrof
    1657. G Petrovski
    1658. JM Phang
    1659. M Piacentini
    1660. M Pierdominici
    1661. P Pierre
    1662. V Pierrefite-Carle
    1663. F Pietrocola
    1664. FX Pimentel-Muiños
    1665. M Pinar
    1666. B Pineda
    1667. R Pinkas-Kramarski
    1668. M Pinti
    1669. P Pinton
    1670. B Piperdi
    1671. JM Piret
    1672. LC Platanias
    1673. HW Platta
    1674. ED Plowey
    1675. S Pöggeler
    1676. M Poirot
    1677. P Polčic
    1678. A Poletti
    1679. AH Poon
    1680. H Popelka
    1681. B Popova
    1682. I Poprawa
    1683. SM Poulose
    1684. J Poulton
    1685. SK Powers
    1686. T Powers
    1687. M Pozuelo-Rubio
    1688. K Prak
    1689. R Prange
    1690. M Prescott
    1691. M Priault
    1692. S Prince
    1693. RL Proia
    1694. T Proikas-Cezanne
    1695. H Prokisch
    1696. VJ Promponas
    1697. K Przyklenk
    1698. R Puertollano
    1699. S Pugazhenthi
    1700. L Puglielli
    1701. A Pujol
    1702. J Puyal
    1703. D Pyeon
    1704. X Qi
    1705. WB Qian
    1706. ZH Qin
    1707. Y Qiu
    1708. Z Qu
    1709. J Quadrilatero
    1710. F Quinn
    1711. N Raben
    1712. H Rabinowich
    1713. F Radogna
    1714. MJ Ragusa
    1715. M Rahmani
    1716. K Raina
    1717. S Ramanadham
    1718. R Ramesh
    1719. A Rami
    1720. S Randall-Demllo
    1721. F Randow
    1722. H Rao
    1723. VA Rao
    1724. BB Rasmussen
    1725. TM Rasse
    1726. EA Ratovitski
    1727. PE Rautou
    1728. SK Ray
    1729. B Razani
    1730. BH Reed
    1731. F Reggiori
    1732. M Rehm
    1733. AS Reichert
    1734. T Rein
    1735. DJ Reiner
    1736. E Reits
    1737. J Ren
    1738. X Ren
    1739. M Renna
    1740. JE Reusch
    1741. JL Revuelta
    1742. L Reyes
    1743. AR Rezaie
    1744. RI Richards
    1745. DR Richardson
    1746. C Richetta
    1747. MA Riehle
    1748. BH Rihn
    1749. Y Rikihisa
    1750. BE Riley
    1751. G Rimbach
    1752. MR Rippo
    1753. K Ritis
    1754. F Rizzi
    1755. E Rizzo
    1756. PJ Roach
    1757. J Robbins
    1758. M Roberge
    1759. G Roca
    1760. MC Roccheri
    1761. S Rocha
    1762. CM Rodrigues
    1763. CI Rodríguez
    1764. SR de Cordoba
    1765. N Rodriguez-Muela
    1766. J Roelofs
    1767. VV Rogov
    1768. TT Rohn
    1769. B Rohrer
    1770. D Romanelli
    1771. L Romani
    1772. PS Romano
    1773. MI Roncero
    1774. JL Rosa
    1775. A Rosello
    1776. KV Rosen
    1777. P Rosenstiel
    1778. M Rost-Roszkowska
    1779. KA Roth
    1780. G Roué
    1781. M Rouis
    1782. KM Rouschop
    1783. DT Ruan
    1784. D Ruano
    1785. DC Rubinsztein
    1786. EB Rucker
    1787. A Rudich
    1788. E Rudolf
    1789. R Rudolf
    1790. MA Ruegg
    1791. C Ruiz-Roldan
    1792. AA Ruparelia
    1793. P Rusmini
    1794. DW Russ
    1795. GL Russo
    1796. G Russo
    1797. R Russo
    1798. TE Rusten
    1799. V Ryabovol
    1800. KM Ryan
    1801. SW Ryter
    1802. DM Sabatini
    1803. M Sacher
    1804. C Sachse
    1805. MN Sack
    1806. J Sadoshima
    1807. P Saftig
    1808. R Sagi-Eisenberg
    1809. S Sahni
    1810. P Saikumar
    1811. T Saito
    1812. T Saitoh
    1813. K Sakakura
    1814. M Sakoh-Nakatogawa
    1815. Y Sakuraba
    1816. M Salazar-Roa
    1817. P Salomoni
    1818. AK Saluja
    1819. PM Salvaterra
    1820. R Salvioli
    1821. A Samali
    1822. AM Sanchez
    1823. JA Sánchez-Alcázar
    1824. R Sanchez-Prieto
    1825. M Sandri
    1826. MA Sanjuan
    1827. S Santaguida
    1828. L Santambrogio
    1829. G Santoni
    1830. CN Dos Santos
    1831. S Saran
    1832. M Sardiello
    1833. G Sargent
    1834. P Sarkar
    1835. S Sarkar
    1836. MR Sarrias
    1837. MM Sarwal
    1838. C Sasakawa
    1839. M Sasaki
    1840. M Sass
    1841. K Sato
    1842. M Sato
    1843. J Satriano
    1844. N Savaraj
    1845. S Saveljeva
    1846. L Schaefer
    1847. UE Schaible
    1848. M Scharl
    1849. HM Schatzl
    1850. R Schekman
    1851. W Scheper
    1852. A Schiavi
    1853. HM Schipper
    1854. H Schmeisser
    1855. J Schmidt
    1856. I Schmitz
    1857. BE Schneider
    1858. EM Schneider
    1859. JL Schneider
    1860. EA Schon
    1861. MJ Schönenberger
    1862. AH Schönthal
    1863. DF Schorderet
    1864. B Schröder
    1865. S Schuck
    1866. RJ Schulze
    1867. M Schwarten
    1868. TL Schwarz
    1869. S Sciarretta
    1870. K Scotto
    1871. AI Scovassi
    1872. RA Screaton
    1873. M Screen
    1874. H Seca
    1875. S Sedej
    1876. L Segatori
    1877. N Segev
    1878. PO Seglen
    1879. JM Seguí-Simarro
    1880. J Segura-Aguilar
    1881. E Seki
    1882. C Sell
    1883. I Seiliez
    1884. CF Semenkovich
    1885. GL Semenza
    1886. U Sen
    1887. AL Serra
    1888. A Serrano-Puebla
    1889. H Sesaki
    1890. T Setoguchi
    1891. C Settembre
    1892. JJ Shacka
    1893. AN Shajahan-Haq
    1894. IM Shapiro
    1895. S Sharma
    1896. H She
    1897. CK Shen
    1898. CC Shen
    1899. HM Shen
    1900. S Shen
    1901. W Shen
    1902. R Sheng
    1903. X Sheng
    1904. ZH Sheng
    1905. TG Shepherd
    1906. J Shi
    1907. Q Shi
    1908. Q Shi
    1909. Y Shi
    1910. S Shibutani
    1911. K Shibuya
    1912. Y Shidoji
    1913. JJ Shieh
    1914. CM Shih
    1915. Y Shimada
    1916. S Shimizu
    1917. DW Shin
    1918. ML Shinohara
    1919. M Shintani
    1920. T Shintani
    1921. T Shioi
    1922. K Shirabe
    1923. R Shiri-Sverdlov
    1924. O Shirihai
    1925. GC Shore
    1926. CW Shu
    1927. D Shukla
    1928. AA Sibirny
    1929. V Sica
    1930. CJ Sigurdson
    1931. EM Sigurdsson
    1932. PS Sijwali
    1933. B Sikorska
    1934. WA Silveira
    1935. S Silvente-Poirot
    1936. GA Silverman
    1937. J Simak
    1938. T Simmet
    1939. AK Simon
    1940. HU Simon
    1941. C Simone
    1942. M Simons
    1943. A Simonsen
    1944. R Singh
    1945. SV Singh
    1946. SK Singh
    1947. D Sinha
    1948. S Sinha
    1949. FA Sinicrope
    1950. A Sirko
    1951. K Sirohi
    1952. BJ Sishi
    1953. A Sittler
    1954. PM Siu
    1955. E Sivridis
    1956. A Skwarska
    1957. R Slack
    1958. I Slaninová
    1959. N Slavov
    1960. SS Smaili
    1961. KS Smalley
    1962. DR Smith
    1963. SJ Soenen
    1964. SA Soleimanpour
    1965. A Solhaug
    1966. K Somasundaram
    1967. JH Son
    1968. A Sonawane
    1969. C Song
    1970. F Song
    1971. HK Song
    1972. JX Song
    1973. W Song
    1974. KY Soo
    1975. AK Sood
    1976. TW Soong
    1977. V Soontornniyomkij
    1978. M Sorice
    1979. F Sotgia
    1980. DR Soto-Pantoja
    1981. A Sotthibundhu
    1982. MJ Sousa
    1983. HP Spaink
    1984. PN Span
    1985. A Spang
    1986. JD Sparks
    1987. PG Speck
    1988. SA Spector
    1989. CD Spies
    1990. W Springer
    1991. DS Clair
    1992. A Stacchiotti
    1993. B Staels
    1994. MT Stang
    1995. DT Starczynowski
    1996. P Starokadomskyy
    1997. C Steegborn
    1998. JW Steele
    1999. L Stefanis
    2000. J Steffan
    2001. CM Stellrecht
    2002. H Stenmark
    2003. TM Stepkowski
    2004. ST Stern
    2005. C Stevens
    2006. BR Stockwell
    2007. V Stoka
    2008. Z Storchova
    2009. B Stork
    2010. V Stratoulias
    2011. DJ Stravopodis
    2012. P Strnad
    2013. AM Strohecker
    2014. AL Ström
    2015. P Stromhaug
    2016. J Stulik
    2017. YX Su
    2018. Z Su
    2019. CS Subauste
    2020. S Subramaniam
    2021. CM Sue
    2022. SW Suh
    2023. X Sui
    2024. S Sukseree
    2025. D Sulzer
    2026. FL Sun
    2027. J Sun
    2028. J Sun
    2029. SY Sun
    2030. Y Sun
    2031. Y Sun
    2032. Y Sun
    2033. V Sundaramoorthy
    2034. J Sung
    2035. H Suzuki
    2036. K Suzuki
    2037. N Suzuki
    2038. T Suzuki
    2039. YJ Suzuki
    2040. MS Swanson
    2041. C Swanton
    2042. K Swärd
    2043. G Swarup
    2044. ST Sweeney
    2045. PW Sylvester
    2046. Z Szatmari
    2047. E Szegezdi
    2048. PW Szlosarek
    2049. H Taegtmeyer
    2050. M Tafani
    2051. E Taillebourg
    2052. SW Tait
    2053. K Takacs-Vellai
    2054. Y Takahashi
    2055. S Takáts
    2056. G Takemura
    2057. N Takigawa
    2058. NJ Talbot
    2059. E Tamagno
    2060. J Tamburini
    2061. CP Tan
    2062. L Tan
    2063. ML Tan
    2064. M Tan
    2065. YJ Tan
    2066. K Tanaka
    2067. M Tanaka
    2068. D Tang
    2069. D Tang
    2070. G Tang
    2071. I Tanida
    2072. K Tanji
    2073. BA Tannous
    2074. JA Tapia
    2075. I Tasset-Cuevas
    2076. M Tatar
    2077. I Tavassoly
    2078. N Tavernarakis
    2079. A Taylor
    2080. GS Taylor
    2081. GA Taylor
    2082. JP Taylor
    2083. MJ Taylor
    2084. EV Tchetina
    2085. AR Tee
    2086. F Teixeira-Clerc
    2087. S Telang
    2088. T Tencomnao
    2089. BB Teng
    2090. RJ Teng
    2091. F Terro
    2092. G Tettamanti
    2093. AL Theiss
    2094. AE Theron
    2095. KJ Thomas
    2096. MP Thomé
    2097. PG Thomes
    2098. A Thorburn
    2099. J Thorner
    2100. T Thum
    2101. M Thumm
    2102. TL Thurston
    2103. L Tian
    2104. A Till
    2105. JP Ting
    2106. VI Titorenko
    2107. L Toker
    2108. S Toldo
    2109. SA Tooze
    2110. I Topisirovic
    2111. ML Torgersen
    2112. L Torosantucci
    2113. A Torriglia
    2114. MR Torrisi
    2115. C Tournier
    2116. R Towns
    2117. V Trajkovic
    2118. LH Travassos
    2119. G Triola
    2120. DN Tripathi
    2121. D Trisciuoglio
    2122. R Troncoso
    2123. IP Trougakos
    2124. AC Truttmann
    2125. KJ Tsai
    2126. MP Tschan
    2127. YH Tseng
    2128. T Tsukuba
    2129. A Tsung
    2130. AS Tsvetkov
    2131. S Tu
    2132. HY Tuan
    2133. M Tucci
    2134. DA Tumbarello
    2135. B Turk
    2136. V Turk
    2137. RF Turner
    2138. AA Tveita
    2139. SC Tyagi
    2140. M Ubukata
    2141. Y Uchiyama
    2142. A Udelnow
    2143. T Ueno
    2144. M Umekawa
    2145. R Umemiya-Shirafuji
    2146. BR Underwood
    2147. C Ungermann
    2148. RP Ureshino
    2149. R Ushioda
    2150. VN Uversky
    2151. NL Uzcátegui
    2152. T Vaccari
    2153. MI Vaccaro
    2154. L Váchová
    2155. H Vakifahmetoglu-Norberg
    2156. R Valdor
    2157. EM Valente
    2158. F Vallette
    2159. AM Valverde
    2160. G Van den Berghe
    2161. L Van Den Bosch
    2162. GR van den Brink
    2163. FG van der Goot
    2164. IJ van der Klei
    2165. LJ van der Laan
    2166. WG van Doorn
    2167. M van Egmond
    2168. KL van Golen
    2169. L Van Kaer
    2170. M van Lookeren Campagne
    2171. P Vandenabeele
    2172. W Vandenberghe
    2173. I Vanhorebeek
    2174. I Varela-Nieto
    2175. MH Vasconcelos
    2176. R Vasko
    2177. DG Vavvas
    2178. I Vega-Naredo
    2179. G Velasco
    2180. AD Velentzas
    2181. PD Velentzas
    2182. T Vellai
    2183. E Vellenga
    2184. MH Vendelbo
    2185. K Venkatachalam
    2186. N Ventura
    2187. S Ventura
    2188. PS Veras
    2189. M Verdier
    2190. BG Vertessy
    2191. A Viale
    2192. M Vidal
    2193. HL Vieira
    2194. RD Vierstra
    2195. N Vigneswaran
    2196. N Vij
    2197. M Vila
    2198. M Villar
    2199. VH Villar
    2200. J Villarroya
    2201. C Vindis
    2202. G Viola
    2203. MT Viscomi
    2204. G Vitale
    2205. DT Vogl
    2206. OV Voitsekhovskaja
    2207. C von Haefen
    2208. K von Schwarzenberg
    2209. DE Voth
    2210. V Vouret-Craviari
    2211. K Vuori
    2212. JM Vyas
    2213. C Waeber
    2214. CL Walker
    2215. MJ Walker
    2216. J Walter
    2217. L Wan
    2218. X Wan
    2219. B Wang
    2220. C Wang
    2221. CY Wang
    2222. C Wang
    2223. C Wang
    2224. C Wang
    2225. D Wang
    2226. F Wang
    2227. F Wang
    2228. G Wang
    2229. HJ Wang
    2230. H Wang
    2231. HG Wang
    2232. H Wang
    2233. HD Wang
    2234. J Wang
    2235. J Wang
    2236. M Wang
    2237. MQ Wang
    2238. PY Wang
    2239. P Wang
    2240. RC Wang
    2241. S Wang
    2242. TF Wang
    2243. X Wang
    2244. XJ Wang
    2245. XW Wang
    2246. X Wang
    2247. X Wang
    2248. Y Wang
    2249. Y Wang
    2250. Y Wang
    2251. YJ Wang
    2252. Y Wang
    2253. Y Wang
    2254. YT Wang
    2255. Y Wang
    2256. ZN Wang
    2257. P Wappner
    2258. C Ward
    2259. DM Ward
    2260. G Warnes
    2261. H Watada
    2262. Y Watanabe
    2263. K Watase
    2264. TE Weaver
    2265. CD Weekes
    2266. J Wei
    2267. T Weide
    2268. CC Weihl
    2269. G Weindl
    2270. SN Weis
    2271. L Wen
    2272. X Wen
    2273. Y Wen
    2274. B Westermann
    2275. CM Weyand
    2276. AR White
    2277. E White
    2278. JL Whitton
    2279. AJ Whitworth
    2280. J Wiels
    2281. F Wild
    2282. ME Wildenberg
    2283. T Wileman
    2284. DS Wilkinson
    2285. S Wilkinson
    2286. D Willbold
    2287. C Williams
    2288. K Williams
    2289. PR Williamson
    2290. KF Winklhofer
    2291. SS Witkin
    2292. SE Wohlgemuth
    2293. T Wollert
    2294. EJ Wolvetang
    2295. E Wong
    2296. GW Wong
    2297. RW Wong
    2298. VK Wong
    2299. EA Woodcock
    2300. KL Wright
    2301. C Wu
    2302. D Wu
    2303. GS Wu
    2304. J Wu
    2305. J Wu
    2306. M Wu
    2307. M Wu
    2308. S Wu
    2309. WK Wu
    2310. Y Wu
    2311. Z Wu
    2312. CP Xavier
    2313. RJ Xavier
    2314. GX Xia
    2315. T Xia
    2316. W Xia
    2317. Y Xia
    2318. H Xiao
    2319. J Xiao
    2320. S Xiao
    2321. W Xiao
    2322. CM Xie
    2323. Z Xie
    2324. Z Xie
    2325. M Xilouri
    2326. Y Xiong
    2327. C Xu
    2328. C Xu
    2329. F Xu
    2330. H Xu
    2331. H Xu
    2332. J Xu
    2333. J Xu
    2334. J Xu
    2335. L Xu
    2336. X Xu
    2337. Y Xu
    2338. Y Xu
    2339. ZX Xu
    2340. Z Xu
    2341. Y Xue
    2342. T Yamada
    2343. A Yamamoto
    2344. K Yamanaka
    2345. S Yamashina
    2346. S Yamashiro
    2347. B Yan
    2348. B Yan
    2349. X Yan
    2350. Z Yan
    2351. Y Yanagi
    2352. DS Yang
    2353. JM Yang
    2354. L Yang
    2355. M Yang
    2356. PM Yang
    2357. P Yang
    2358. Q Yang
    2359. W Yang
    2360. WY Yang
    2361. X Yang
    2362. Y Yang
    2363. Y Yang
    2364. Z Yang
    2365. Z Yang
    2366. MC Yao
    2367. PJ Yao
    2368. X Yao
    2369. Z Yao
    2370. Z Yao
    2371. LS Yasui
    2372. M Ye
    2373. B Yedvobnick
    2374. B Yeganeh
    2375. ES Yeh
    2376. PL Yeyati
    2377. F Yi
    2378. L Yi
    2379. XM Yin
    2380. CK Yip
    2381. YM Yoo
    2382. YH Yoo
    2383. SY Yoon
    2384. K Yoshida
    2385. T Yoshimori
    2386. KH Young
    2387. H Yu
    2388. JJ Yu
    2389. JT Yu
    2390. J Yu
    2391. L Yu
    2392. WH Yu
    2393. XF Yu
    2394. Z Yu
    2395. J Yuan
    2396. ZM Yuan
    2397. BY Yue
    2398. J Yue
    2399. Z Yue
    2400. DN Zacks
    2401. E Zacksenhaus
    2402. N Zaffaroni
    2403. T Zaglia
    2404. Z Zakeri
    2405. V Zecchini
    2406. J Zeng
    2407. M Zeng
    2408. Q Zeng
    2409. AS Zervos
    2410. DD Zhang
    2411. F Zhang
    2412. G Zhang
    2413. GC Zhang
    2414. H Zhang
    2415. H Zhang
    2416. H Zhang
    2417. H Zhang
    2418. J Zhang
    2419. J Zhang
    2420. J Zhang
    2421. J Zhang
    2422. JP Zhang
    2423. L Zhang
    2424. L Zhang
    2425. L Zhang
    2426. L Zhang
    2427. MY Zhang
    2428. X Zhang
    2429. XD Zhang
    2430. Y Zhang
    2431. Y Zhang
    2432. Y Zhang
    2433. Y Zhang
    2434. Y Zhang
    2435. M Zhao
    2436. WL Zhao
    2437. X Zhao
    2438. YG Zhao
    2439. Y Zhao
    2440. Y Zhao
    2441. YX Zhao
    2442. Z Zhao
    2443. ZJ Zhao
    2444. D Zheng
    2445. XL Zheng
    2446. X Zheng
    2447. B Zhivotovsky
    2448. Q Zhong
    2449. GZ Zhou
    2450. G Zhou
    2451. H Zhou
    2452. SF Zhou
    2453. XJ Zhou
    2454. H Zhu
    2455. H Zhu
    2456. WG Zhu
    2457. W Zhu
    2458. XF Zhu
    2459. Y Zhu
    2460. SM Zhuang
    2461. X Zhuang
    2462. E Ziparo
    2463. CE Zois
    2464. T Zoladek
    2465. WX Zong
    2466. A Zorzano
    2467. SM Zughaier
    (2016)
    Autophagy 12:1–222.
    https://doi.org/10.1080/15548627.2015.1100356
  37. 37
  38. 38
  39. 39
  40. 40
    Cdk5: a key player at neuronal synapse with diverse functions
    1. KO Lai
    2. NY Ip
    (2015)
    Mini Reviews in Medicinal Chemistry 15:390–395.
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78
  79. 79
  80. 80
  81. 81
  82. 82
  83. 83
  84. 84
  85. 85
  86. 86
  87. 87
  88. 88
  89. 89
  90. 90
  91. 91
  92. 92
  93. 93

Decision letter

  1. Hong Zhang
    Reviewing Editor; Institute of Biophysics, Chinese Academy of Sciences, China

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article "Stress-Induced Cdk5 Activity Enhances Cytoprotective Basal Autophagy by Phosphorylating Acinus at Serine437" for consideration by eLife. Your article has been favorably evaluated by Ivan Dikic (Senior Editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Autophagy is a critical mediator of neuronal cell health. Ongoing basal clearance of aggregated or damaged proteins is associated with protection from neurodegeneration in both flies and humans. Previous studies from the authors identified a role for the Acinus (Acn) protein in promoting basal autophagy. In this manuscript, you provide evidence that Cdk5 genetically interacts with Acn to regulate basal level of autophagy, and that Cdk5 phosphorylates Acn at S437 to modulate its stability. The phospho-mimetic AcnS437D promotes basal autophagy and rescues defects (e.g. reduced basal autophagy and shortened life span) of p35 mutants. You further demonstrate enhancement of the Cdk5/Acn-pS437 pathway in response to polyQ protein accumulation. Cdk5 was previously implicated in maintenance of neuronal health. This study identifies Acinus as a relevant target of Cdk5 activity as a compelling basis for this role. Overall, the findings are interesting and potentially important. The experiments are well executed and most conclusions are well supported by the data presented in this work. This manuscript will be suitable for publication in eLife after appropriate revisions.

Essential revisions:

1) In vitro kinase assays with purified proteins to show that Cdk5 kinase can directly phosphorylate Acinus.

2) The current data does not sufficiently support the conclusion that autophagy activity is induced by S437-Acn. The authors showed that the number of Atg8a puncta and LysoTracker-positive structures is increased in AcnS437D larval fat bodies. The autolysosomes in AcnS437D larval fat bodies are much larger and more abundant compared to AcnWT. The mean diameter of lysosomal/autolysosome structures is even increased more than 8-fold! Inhibition of autophagy at the step of autophagosome maturation and/or degradation results in the same phenotype. Does starvation-induced autophagy also cause accumulation of enlarged autolysosomes in fat bodies? Additional characterization of autophagy flux would strengthen the interpretations of autophagy induction induced by Acn-pS437. This could be achieved with assays using the tandem fluorescent Atg8 reporter and/or Atg8-II levels in animals fed BafilomycinA.

https://doi.org/10.7554/eLife.30760.031

Author response

Essential revisions:

1) in vitro kinase assays with purified proteins to show that Cdk5 kinase can directly phosphorylate Acinus.

We performed two sets of experiments to address this concern.

First, we prepared GST proteins fused to Acn402-527 (WT or S437A) and exposed them to phosphorylation with commercially available Cdk5/p35 complexes (Σ; 14-477). We observed Cdk5/p35-dependent S437-phosphorylation, that was not present in S437A controls (new Figure 6J). Of note, we tried several other GST-Acn fusions for these experiments, but none was more stable against degradation than the GST-Acn-402-527 fusions.

Second, we over-expressed Strep-tag and Myc-tagged full-length Acinus proteins (WT or S437A) in S2 cells, immobilized and purified the proteins on Strep-Tactin beads before incubation with commercial Cdk5/p35. These experiments also showed Cdk5/p35-dependent S437-Acn phosphorylation (new Figure 6K).

In combination, we believe these experiments convincingly address the reviewers’ concerns to show that Cdk5 kinase can directly phosphorylate Acinus at S437.

2) The current data does not sufficiently support the conclusion that autophagy activity is induced by S437-Acn. The authors showed that the number of Atg8a puncta and LysoTracker-positive structures is increased in AcnS437D larval fat bodies. The autolysosomes in AcnS437D larval fat bodies are much larger and more abundant compared to AcnWT. The mean diameter of lysosomal/autolysosome structures is even increased more than 8-fold! Inhibition of autophagy at the step of autophagosome maturation and/or degradation results in the same phenotype. Does starvation-induced autophagy also cause accumulation of enlarged autolysosomes in fat bodies?

Starvation-induced autophagy in fat bodies has been extensively studied by multiple labs. Examples include: (Scott et al., 2004) (Takats et al., 2014) (Takats et al., 2013). Neither of these papers quantified the changes in size from basal to starvations-induced autolysosomes. Importantly, however, all of these papers showed examples of electron micrographs from starved tissues containing large autolysosomes exceeding 1 µm or even 2 µm (e.g. Figure 2B-D in (Scott et al., 2004); Figure 2I in (Takats et al., 2013); or Figure 4A,B in (Takats et al., 2014).

Additional characterization of autophagy flux would strengthen the interpretations of autophagy induction induced by Acn-pS437. This could be achieved with assays using the tandem fluorescent Atg8 reporter and/or Atg8-II levels in animals fed BafilomycinA.

To address this concern, we performed experiments in which we blocked lysosomal acidification and degradation in larval fat bodies by feeding chloroquine to larvae following a well-established protocol to measure autophagic flux in larval fat bodies (Low et al., 2013; Mauvezin et al., 2014; Lorincz et al., 2017). When staining these chloroquine-treated fat bodies for endogenous ATG8, we observed significant increases in ATG8a punctae and ATG8a signal intensity for wild-type starved or for fed S437D phospho-mimetic mutants consistent with increased autophagic flux (new Figure 2E-L and Figure 2—figure supplement 1).

To keep this figure manageable, we have split the previous Figure 2 and separated the analysis of the effects of S437A and S437D mutants on starvation-resistance and longevity into the new Figure 3.

In addition, we like to point out that the beneficial effects endowed by the S437D phospho-mimetic mutation on starvation-resistance (new Figure 3A), longevity (new Figures 3B, 7M), and suppression of polyQ protein accumulation (new Figure 8) would be hard to explain as a consequence of defects in lysosomal degradation or reduced autophagosome maturation. By contrast, these effects are entirely consistent with beneficial effects of increased autophagy in the context of longevity and proteinopathies previously reported by several labs (some of many examples: (Sarkar et al., 2007; Simonsen et al., 2008; Nandi et al., 2014; Menzies et al., 2015; Gelino et al., 2016). We have now addressed this issue in the first paragraph of the Discussion.

https://doi.org/10.7554/eLife.30760.032

Article and author information

Author details

  1. Nilay Nandi

    Department of Neuroscience, UT Southwestern Medical Center, Dallas, United States
    Contribution
    Formal analysis, Investigation, Methodology, Writing—original draft, Writing—review and editing
    Competing interests
    No competing interests declared
    ORCID icon 0000-0002-7088-4943
  2. Lauren K Tyra

    Department of Neuroscience, UT Southwestern Medical Center, Dallas, United States
    Contribution
    Investigation, Writing—review and editing
    Competing interests
    No competing interests declared
  3. Drew Stenesen

    Department of Neuroscience, UT Southwestern Medical Center, Dallas, United States
    Contribution
    Investigation, Writing—review and editing
    Competing interests
    No competing interests declared
  4. Helmut Krämer

    1. Department of Neuroscience, UT Southwestern Medical Center, Dallas, United States
    2. Department of Cell Biology, UT Southwestern Medical Center, Dallas, United States
    Contribution
    Conceptualization, Supervision, Funding acquisition, Visualization, Writing—original draft, Project administration, Writing—review and editing
    For correspondence
    helmut.kramer@utsouthwestern.edu
    Competing interests
    No competing interests declared
    ORCID icon 0000-0002-1167-2676

Funding

National Eye Institute (EY010199)

  • Helmut Krämer

National Science Foundation (4900835401-36068)

  • Lauren K Tyra

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

We thank Drs. Karine Pozo and Qing Zhong for helpful comments to the manuscript and members of the Kramer lab for discussion and technical assistance. We thank Charles Tracy for performing the RT-qPCR assays. We thank Drs. Thomas Neufeld, Robin Hiesinger, Edward Giniger, Alysia Vrailas-Mortimer, Vienna Drosophila Resource Center, and the Bloomington Stock Center (NIH P40OD018537) for flies, Gàbor Juhàsz and the Developmental Studies Hybridoma Bank at The University of Iowa for antibodies and the Molecular and Cellular Imaging Facility at UT Southwestern Medical Center for help with electron microscopy. This work was funded by NIH grant EY010199 to HK and NSF Graduate Research Fellowship (4900835401–36068) to LKT.

Reviewing Editor

  1. Hong Zhang, Reviewing Editor, Institute of Biophysics, Chinese Academy of Sciences, China

Publication history

  1. Received: July 26, 2017
  2. Accepted: December 8, 2017
  3. Accepted Manuscript published: December 11, 2017 (version 1)
  4. Version of Record published: January 9, 2018 (version 2)

Copyright

© 2017, Nandi et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 756
    Page views
  • 186
    Downloads
  • 3
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Cell Biology
    Yubing Liu et al.
    Research Article Updated
    1. Cell Biology
    2. Microbiology and Infectious Disease
    John D Chan et al.
    Research Article Updated